Genetically Encoded 3,4-Ethylenedioxythiophene (EDOT) Functionality for Fabrication of Protein-Based Conductive Polymers by Obana, Maiko
Genetically encoded 3,4-ethylenedioxythiophene (EDOT) 






In Partial Fulfillment of the Requirements 
for the Degree of 


































First and foremost, I would like to thank my thesis advisor, Prof. David Tirrell, for his 
guidance and support. In the beginning of my graduate studies, I struggled to find a project 
I would like to pursue for my PhD. He kindly listened to me about my research interest and 
guided me to work on a project I really enjoyed throughout my PhD. I also appreciate his 
respect to his students. Dave always allows us to think on our own. Although I was 
unconfident about myself when I started at Caltech, I learned to think myself as an 
independent scientist over the course of my PhD. Thank you for everything, Dave. 
I would like to thank to the members of my thesis committee, Prof. Jacqueline Barton, Prof. 
Julia Kornfield, and Prof. Maxwell Robb, for their support and advice. Committee 
meetings were always fun and helpful, and I appreciate many constructive comments on 
my project from all the different perspectives. 
I would like to thank to past and present members of the Tirrell group, for a supportive and 
fun environment. I learned not only technical skills, but also a mindful attitude from my 
colleagues. I would especially like to thank Dr. Bradley Silverman for working with me on 
the colloidal assembly project in my first year. He kindly and patiently taught me molecular 
biology techniques when I literally knew nothing about cloning and protein expression as a 
first-year student. The project could not have been done without his careful image analysis 
and constructive discussions. Thanks to Dr. Samuel Ho and Stephanie Breunig for their 
advice on my research in the Protein Modification subgroup as well as working with me as 
safety coordinators. They are always easy to talk to and I really appreciate their willingness 
to provide any help anytime. Thanks to Dr. Shannon Stone and Dr. Lawrence Dooling for 
helpful advice, especially for helpful discussions when I was struggling to find a project to 
work on during my PhD.   
I would also like to thank Prof. Edmund Tse, a former postdoc in the Barton group, for 
technical assistance with electrochemistry experiments and discussions. Thanks to Dr. 
Mona Shahgholi at the Mass Spectrometry Laboratory for her help with mass spectrometry 
analysis. Thanks to Dr. Daisuke Saito, Dr. Naoyuki Suzuki, and Dr. Yasuaki Nakayama, 
 iv 
who are former postdocs in the Stoltz group and the Reisman group, for the helpful 
advice in amino acid synthesis. Thanks to Jiajun Du for assistance with Raman 
spectroscopy, Kai Narita for assistance with conductivity measurement, and Dr. Jeong 
Hoon Ko for a lot of helpful discussions throughout my research. Thanks to people in the 
Barton group, especially Dr. Rebekah Silva for always welcoming me to use their 
potentiostat. Thanks to the Nakajima Foundation for the financial support over the five 
years of my Ph.D. I also would like to thank Dr. Takahiro Fukino, Prof. Keiichiro Kushiro, 
and my undergraduate advisor Prof. Takuzo Aida. Without their support and 
encouragement, I could not have taken on the challenge to study abroad for my PhD. 
Thanks to all my friends, especially to Tomoyuki Oniyama, Silvia Kim, Jieun Shin. 
Making friends with people like you was one of the greatest parts of graduate school. 
Thanks to all my friends in the Japanese and the Korean Tennis Clubs, and the Caltech 
Japanese Student Association. Especially thanks to Mooseok Jang, Albert Chung, and 
Sonjong Hwang for training tennis with me every week (or sometimes five days a week). 
Thanks to Yoshihiro Nakayama, Andy Brown, and all of the Pasadena Ultimate Frisbee 
friends. Ultimate is the greatest thing I learned during graduate school besides science. 
Finally, I would like to thank my family. I grew up in a little rural town in Japan, so 
allowing me to study in Tokyo for college and then the US for graduate school must have 
been difficult for my parents. But they accepted me whatever I wanted to do, and they were 
always supportive. Thanks to my older sister, who has been a great friend throughout my 
life. Thanks to my parents-in-law Christine and Richard, for welcoming me into their 
family. Thanks to my husband Kevin, who always gives me tremendous support in my life 






Genetic code expansion provides powerful strategies to improve the properties of protein-
based materials. One novel application of this technique is to genetically incorporate an 
electroactive functional group into proteins, which can be subsequently polymerized into 
conductive polymers, enabling fabrication of various protein–conductive polymer hybrids 
that are widely applicable in bioelectronics. To this end, we developed a technique to 
incorporate an amino acid bearing 3,4-ethylenedioxythiophene (EDOT), the monomer 
precursor of a well-known conductive polymer PEDOT. 
In Chapter 1, we review the basics of protein-based materials and genetic code expansion 
technology. We also highlight some examples where genetic code expansion was used for 
the development of protein-based materials. Finally, we discuss applications of protein and 
peptide-based materials in bioelectronics. 
In Chapter 2, we describe our effort to incorporate an amino acid bearing EDOT group 
(EDOT-Ala) designed as an analogue of aromatic canonical amino acids. We synthesized 
EDOT-Ala in three steps of organic reaction, and evaluated the activity of known 
aminoacyl-tRNA synthetase (aaRS) variants for EDOT-Ala. In addition, we performed 
evolution of aaRS for EDOT-Ala using two different evolution techniques: cell viability-
based approach and phage-assisted approach. Although the evolution experiment did not 
yield an aaRS variant that can incorporate EDOT-Ala, the results presented in this chapter 
provide valuable information for engineering of aaRS and incorporation of non-canonical 
amino acids (ncAA) with bulky functional groups. 
In Chapter 3, we describe the incorporation of another EDOT-functionalized amino acid 
(EDOT-Lys) designed as an analogue of a canonical amino acid pyrrolysine (Pyl). When 
we co-expressed a GFP reporter and a mutant pyrrolysyl-tRNA synthetase (PylRS) in E. 
coli in the presence of EDOT-Lys, the cells exhibited strong fluorescence as an indication 
of successful incorporation of EDOT-Lys into GFP. We further confirmed the 
incorporation using MALDI-TOF mass spectrometry. 
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In Chapter 4, we describe the electropolymerization of a model protein XTEN that carries 
genetically incorporated EDOT-Lys (XTEN-E49am). We performed electropolymerization 
of XTEN-E49am in the presence of a self-doping EDOT monomer (EDOT-S) by cyclic 
voltammetry. The solution formed dark blue solids immediately after the potential cycles. 
The composition of the product was determined by FT-IR spectroscopy, suggesting that 
one protein is found per 12.5 monomer units of PEDOT. In addition, we investigated the 
effect of amino acids located adjacent to EDOT-Lys. Although the presence of cysteine 
(Cys), lysine (Lys), methionine (Met), arginine (Arg), and tryptophan (Trp) located 
adjacent to EDOT-Lys had an impact on the electropolymerization of model peptides, 
XTEN proteins carrying these adjacent residues (XTEN-E49am-G50Z; Z = Cys, Lys, Met, 
Arg, Trp) were electropolymerized with EDOT-S without noticeable effect from these 
adjacent residues, indicating that the EDOT-Lys residues in proteins undergo 
electropolymerization with EDOT-S in different chemical environments. 
In Chapter 5, we describe the oxidative chemical polymerization of XTEN proteins and 
model peptides. When XTEN-E49am was polymerized with EDOT-S by addition of 
ammonium persulfate (APS) and iron(III) chloride (FeCl3), the solution yielded dark blue 
solids. To evaluate the reactivity of the EDOT-Lys residue in the protein, we reacted the 
protein with an end-capped EDOT derivative (EDOT-cap). MALDI-TOF mass 
spectrometry revealed the appearance of new peaks corresponding to the addition of one or 
two EDOT-caps to the protein, suggesting that EDOT-Lys residue in the protein can react 
with EDOT derivatives. We also investigated the effect of adjacent amino acids using a 
series of model peptides. In polymerization using APS without FeCl3 catalyst, peptides 
carrying basic amino acids (His, Lys, Arg) adjacent to EDOT-Lys showed enhanced 
polymerization compared to the ones carrying neutral and acidic adjacent residues. All the 
tested peptides polymerized well when FeCl3 was added as a catalyst. The results presented 
in this chapter provide valuable insights into synthesis of protein–PEDOT conjugates via 
oxidative chemical polymerization. 
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C h a p t e r  1  
PROTEIN-BASED MATERIALS 
1.1. Introduction 
With unique structural and functional properties, proteins have attracted significant 
attention as a source of biomaterials. Diverse protein-based materials have been 
developed by adapting natural proteins and by rational and computational design. 
The properties of protein-based materials can be further improved by protein 
modification via post-translational and co-translational methods. Genetic code 
expansion is a powerful protein modification technique that enables incorporation 
of non-canonical amino acids (ncAAs) into proteins. This technique is especially 
useful in introducing new functions to protein-based materials while taking 
advantage of inherent properties of the proteins. One novel application of genetic 
code expansion is to introduce an electroactive functional group into proteins in 
order to form conductive polymers. The overall goal of this thesis project is to 
incorporate an electroactive ncAA into proteins for the fabrication of protein-based 
conductive materials. In this introductory chapter, we describe protein-based 
materials and the improvement of their properties by genetic code expansion. We 








1.2. Protein-Based Materials 
Proteins are highly attractive sources of biomaterials because of their unique 
structural and functional properties. They have evolved to perform a vast array of 
functions in living organisms, including catalysis, recognition, and structural 
support. By adapting the sequences of proteins from nature, various protein-based 
materials have been developed.1–4 Typical examples are based on structural proteins 
such as elastin, silk, and collagen elastin (Figure 1.1).2 These structural proteins are 
not only used in their full natural forms, but their repeated motifs are also used as 
building blocks to produce biomaterials. For example, the hydrophobic domains of 
elastin are adapted to synthesize elastin-like polypeptides (ELPs), recapturing the 
elasticity and thermal responsiveness of the original domains.3  
 
Figure 1.1. Natural proteins commonly used for protein-based materials. Adapted from ref. 
2. 
With the better understanding of the relationship between the sequences and the 
properties of proteins in recent decades, various protein-based materials have been 
developed by rational and computational designs.1,5–8 Secondary motifs such as α-
helices and β-sheets are the critical elements in facilitating the formation of higher-
order protein assemblies and serve as the building blocks in designing protein-based 
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materials.6,7 While each interaction is usually too weak to achieve sufficient affinity 
to assemble proteins, a bundle of the interactions exhibits a much stronger force, 
facilitating protein association. Various motifs and sequences have been used to 
form unique protein assemblies such as filaments, cages, and cross-linked 
networks.1,3,6,7 
When necessary, protein modification via post-translational or co-translational 
methods is employed to improve the properties of protein-based materials.9–12 
Bioconjugation at the reactive residues such as cysteine and lysine is commonly 
used for labeling proteins with functional molecules.12,13 Enzymatic modification 
also provides a powerful strategy to functionalize proteins with high sequence 
specificity and mild reaction conditions.12,14,15 Various enzymes such as 
transglutaminases, peroxidases, sortase, and biotin ligase are employed to modify 
proteins at specific residues or sequences. Proteins can be also modified co-
translationally by a technique known as genetic code expansion, which utilizes non-
canonical amino acids (ncAAs) to introduce novel functionalities into proteins.9,10 
We discuss genetic code expansion and its application for the development of 
protein-based materials in the next section. 
1.3. Genetic Code Expansion for Protein-Based Materials 
In contrast to conventional synthetic polymers, proteins can be prepared with 
perfect control of size, sequence, and stereochemistry through gene expression. 
However, their chemical diversity is limited to the functional groups that comprise 
the side chains of twenty canonical amino acids. To circumvent this limitation, 
protein chemists have developed a powerful strategy to introduce novel 
functionality into proteins by incorporation of non-canonical amino acids 
(ncAAs).10,16–19 Since the seminal work by Cowie and Cohen in the 1950s to 
incorporate selenomethionine as a replacement for methionine,20 hundreds of 
ncAAs have been incorporated into proteins.10,16–19  
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The key to incorporation of ncAAs is the aminoacylation step in protein 
biosynthesis (Figure 1.2).10,16–19 During aminoacylation, enzymes known as 
aminoacyl-tRNA synthetases (aaRSs) charge amino acids to their cognate tRNAs, 
and the aminoacylated tRNAs are subsequently used for translation at the ribosome, 
integrating the amino acids into polypeptide chains. Because the ribosome has 
relaxed substrate specificity, the limiting step to incorporate ncAAs is recognition 
by aaRS during aminoacylation. Once ncAAs are charged to tRNAs, they can be 
incorporated into the protein during translation. 
 
Figure 1.2. Protein biosynthesis and incorporation of ncAA. (a) Aminoacylation. (b) 
Translation. 
There are two major approaches to incorporate ncAAs: the residue-specific method 
and the site-specific method.10,16–19 The residue-specific method globally replaces 
one of the canonical amino acids with a non-canonical analogue. The cognate 
tRNA for a specific canonical amino acid is charged with ncAA by aaRS, and the 
ncAA is assigned to the codons for the canonical amino acid. To avoid the 
competition with the canonical amino acid, incorporation is often performed using 
an auxotrophic cell strain and minimal media lacking the canonical amino acid. In 
the site-specific method, ncAA is only incorporated at a specific codon, usually one 
of the three stop codons. A nonsense suppressor, an engineered tRNA that 
recognizes a stop codon, is charged with ncAA by aaRS and inserts the ncAA at the 
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target site. These two approaches are complementary to each other and applied for 
various purposes including bioorthogonal reactions, proteomic study, cross-linking, 
study of posttranslational modification, and spectroscopic probes.10,16–19 
Various studies have shown that ncAAs can be effectively employed for the 
development of protein-based materials.9,10 Typical examples are functionalization 
of protein-based materials using ncAAs as reactive handle. Strable and coworkers 
incorporated azidohomoalanine (Aha) and homopropargylglycine (HPG) into virus-
like particles and labeled the particles with a variety of reagents via copper(I)-
catalyzed azide–alkyne cycloaddition (CuAAC).21 In another report, they 
functionalized the virus particles with gadolinium complexes using Aha and studied 
the plasma clearance and tissue distribution of the particles in mice.22 p-
Aminophenylalanine (NH2-Phe) was also employed for functionalization of MS2 
virus capsid with DNA aptamers via oxidative coupling, and the modified virus 
capsid was successfully targeted to cancer cells.23 For the functionalization of 
proteins with a synthetic polymer, incorporation of a phenylalanine derivative 
carrying the initiator of atom transfer radical polymerization (ATRP) has been 
demonstrated.24 The subsequent polymerization successfully produced protein–
polymer conjugates. The use of ncAA is not limited to proteins expressed in 
bacterial hosts. Teramoto and coworkers developed transgenic silkworms (Bombyx 
mori) and incorporated p-azidophenylalanine (N3-Phe) into silk fibroin.25,26 The 
resulting silk fibers were able to react with alkyne-funtionalized fluorophore via 
CuAAC. 
NcAAs with a photo-reactive functional group have also been employed to control 
material properties in response to UV irradiation. Carrico and coworkers 
demonstrated the lithographic patterning of artificial extracellular matrix proteins 
using N3-Phe as photo-crosslinking agent.27 The elastic moduli of the films were 
controlled by the amount of N3-Phe incorporated into the protein,27,28 and 
mammalian cells adhered selectively to the region of the surface patterning of the 
protein film.27  This technique was later used for the generation of protein surface 
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gradients in the microfluidic device.29 Another example is mussel adhesive protein 
incorporated with a photo-caged 3,4-dihydroxyphenylalanine (DOPA) derivative.30 
Cleavage of nitrobenzyl groups by UV irradiation unmasked catechol side chains of 
DOPA and enhanced the adhesive property of the protein. Incorporation of ncAAs 
appears to be especially useful in introducing new functions to proteins while 
taking advantage of inherent properties of the proteins. 
1.4. Bioelectronics Applications of Proteins and Peptides 
With favorable mechanical properties, designability and biocompatibility, materials 
based on proteins and peptides are especially attractive for bioelectronics 
applications.31–33 In order to introduce electrical conductivity, inorganic and organic 
conductors are often integrated with protein and peptide-based materials, producing 
biohybrid materials.33–38 One of the major roles of proteins and peptides in the 
conductive biohybrid materials is to serve as structural support.34 Protein fibers 
such as amyloids, silk, and elastin have been used as templates for assembly of 
metal nanoparticles to form protein nanowires.39–44 Various virus particles have also 
been used to assemble metals and semiconductors.45 Materials assembled from 
proteins and peptides offer advantages such as precise and tunable spatial control 
and the versatility of surface chemistry, and can be applied for biosensors, 
supercapacitors, and organic solar cells.40,43,46 
 In addition, proteins and peptides can be genetically programmed in the cells to 
serve as essential components of engineered living materials.47–49 For example, 
Chen and coworkers engineered E. coli to produce curli amyloid fibrils in defined 
patterns and formed the network of gold nanoparticles in the biofilm.47 Using 
multiple variants of the protein component CsgA, they demonstrated the assembly 
of nanoparticles into different patterns such as nanowires and nanorods. Nguyen 
and coworkers also developed biofilm-based materials using engineered curli 
nanofibers.48 They fused a variety of functional peptides with the CsgA protein and 
demonstrated the assembly of silver nanoparticles and the cellular adhesion to 
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stainless steel. These examples illustrate the utility of protein and peptide 
assemblies to integrate inorganic conductive materials into the living system. 
Protein- and peptide-based materials are also combined with carbon-based materials 
and conductive polymers.36,37 Silk fibers, elastin-like polypeptide (ELP) hydrogels, 
and keratin-based fibers have been integrated with carbon nanotubes (CNTs), 
graphene, and graphene oxide to introduce electrical conductivity.50–59 Amyloid 
fibrils and silks are also coated with conductive polymers such as polyaniline 
(PANI) and poly(3,4-ethylenedioxythiophene) (PEDOT) to form conductive 
nanowires.60–65 The electrode composed of PEDOT-coated silk fiber was employed 
for electrophysiological recording in rats and successfully recorded the brain and 
cardiac activity.66 Due to good mechanical compatibility with soft biological 
tissues, the composites of conductive polymers and proteins are especially suitable 
for the interface materials in bioelectronics. 
Besides the structural support of biohybrid materials, proteins and peptides are also 
responsible for interactions with biological systems. Proteins and peptides in 
conductive biohybrids create a biocompatible interface that supports cell adhesion, 
and thereby stabilize cell proliferation and differentiation. Extracellular matrix 
(ECM) proteins such as collagen and fibronectin are often combined with carbon-
based materials to improve their cell adhesive property.57,67–72 Peptide motifs 
derived from ECM proteins (e.g. RGD, IKVAV) have also been introduced to 
conductive polymers in order to enhance cell adhesion, growth, and 
differentiation.73–76 These materials are able to conduct electrical current through 
biological samples and especially useful for cell culture materials and neural 
probes, enabling electrical stimulation of the cells and recording the cellular 
activity.77,78 The ability of peptides to specifically interact with biomolecules is also 
exploited for biosensors. Peptides binding to various biomolecules such as DNA, 
proteins, viruses, and small molecules have been combined with conductive 
materials and shown to detect the target molecules on the electrode.79–82 Because 
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peptides can be engineered to bind a wide range of substances,83–85 these techniques 
provide versatile platforms for diagnosis and monitoring. 
1.5. Conclusion 
In addition to diverse structural and functional properties, protein-based materials 
can be further improved using protein engineering techniques. Genetic code 
expansion is a powerful strategy to introduce new functionalities into proteins and 
has contributed to the development of protein-based materials. One novel 
application of this technique is to introduce an electroactive functional group into 
proteins that can be subsequently polymerized into conductive polymers. The 
resulting protein–conductive polymer hybrids are useful for various bioelectronics 
applications such as cell culture materials for electrical stimulation, interface for 
bioelectronic devices, and conductive living materials. 
1.6. References 
(1)  H. Smith, K.; Montes, E. T.; Poch, M.; Mata, A. Integrating Top-down and 
Self-Assembly in the Fabrication of Peptide and Protein-Based Biomedical 
Materials. Chem. Soc. Rev. 2011, 40 (9), 4563–4577. 
(2)  Hu, X.; Cebe, P.; Weiss, A. S.; Omenetto, F.; Kaplan, D. L. Protein-Based 
Composite Materials. Mater. Today 2012, 15 (5), 208–215. 
(3)  Gagner, J. E.; Kim, W.; Chaikof, E. L. Designing Protein-Based 
Biomaterials for Medical Applications. Acta Biomater. 2014, 10 (4), 1542–
1557. 
(4)  Desai, M. S.; Lee, S. W. Protein-Based Functional Nanomaterial Design 
for Bioengineering Applications. Wiley Interdiscip. Rev. Nanomedicine 
Nanobiotechnology 2015, 7 (1), 69–97. 
(5)  Tu, R. S.; Tirrell, M. Bottom-up Design of Biomimetic Assemblies. Adv. 
Drug Deliv. Rev. 2004, 56 (11), 1537–1563. 
(6)  Luo, Q.; Hou, C.; Bai, Y.; Wang, R.; Liu, J. Protein Assembly: Versatile 
Approaches to Construct Highly Ordered Nanostructures. Chem. Rev. 2016, 
116 (22), 13571–13632. 
(7)  Yang, Y. J.; Holmberg, A. L.; Olsen, B. D. Artificially Engineered Protein 
Polymers. Annu. Rev. Chem. Biomol. Eng. 2017, 8, 549–575. 
(8)  Yeates, T. O. Geometric Principles for Designing Highly Symmetric Self-
 9 
Assembling Protein Nanomaterials. Annu. Rev. Biophys. 2017, 46, 23–42. 
(9)  Connor, R. E.; Tirrell, D. A. Non-Canonical Amino Acids in Protein 
Polymer Design. Polym. Rev. 2007, 47 (1), 9–28. 
(10)  Johnson, J. A.; Lu, Y. Y.; Van Deventer, J. A.; Tirrell, D. A. Residue-
Specific Incorporation of Non-Canonical Amino Acids into Proteins: 
Recent Developments and Applications. Curr. Opin. Chem. Biol. 2010, 14 
(6), 774–780. 
(11)  Witus, L. S.; Francis, M. B. Using Synthetically Modified Proteins to Make 
New Materials. Acc. Chem. Res. 2011, 44 (9), 774–783. 
(12)  Spicer, C. D.; Pashuck, E. T.; Stevens, M. M. Achieving Controlled 
Biomolecule-Biomaterial Conjugation. Chem. Rev. 2018, 118 (16), 7702–
7743. 
(13)  Boutureira, O.; Bernardes, G. J. L. Advances in Chemical Protein 
Modification. Chem. Rev. 2015, 115 (5), 2174–2195. 
(14)  Sunbul, M.; Yin, J. Site Specific Protein Labeling by Enzymatic 
Posttranslational Modification. Org. Biomol. Chem. 2009, 7 (17), 3361–
3371. 
(15)  Rashidian, M.; Dozier, J. K.; Distefano, M. D. Enzymatic Labeling of 
Proteins: Techniques and Approaches. Bioconjug. Chem. 2013, 24 (8), 
1277–1294. 
(16)  Link, A. J.; Mock, M. L.; Tirrell, D. A. Non-Canonical Amino Acids in 
Protein Engineering. Curr. Opin. Biotechnol. 2003, 14 (6), 603–609. 
(17)  Wang, L.; Schultz, P. G. Expanding the Genetic Code. Angew. Chemie - Int. 
Ed. 2004, 44 (1), 34–66. 
(18)  Liu, C. C.; Schultz, P. G. Adding New Chemistries to the Genetic Code. 
Annu. Rev. Biochem. 2010, 79, 413–444. 
(19)  Dumas, A.; Lercher, L.; Spicer, C. D.; Davis, B. G. Designing Logical 
Codon Reassignment-Expanding the Chemistry in Biology. Chem. Sci. 
2015, 6 (1), 50–69. 
(20)  Cowie, D. B.; Cohen, G. N. Biosynthesis by Escherichia Coli of Active 
Altered Proteins Containing Selenium Instead of Sulfur. BBA - Biochim. 
Biophys. Acta 1957, 26 (2), 252–261. 
(21)  Strable, E.; Prasuhn, D. E.; Udit, A. K.; Brown, S.; Link, A. J.; Ngo, J. T.; 
Lander, G.; Quispe, J.; Potter, C. S.; Carragher, B.; Tirrell, D. A.; Finn, M. 
G. Unnatural Amino Acid Incorporation into Virus-like Particles. 
Bioconjug. Chem. 2008, 19 (4), 866–875. 
(22)  Prasuhn, D. E.; Singh, P.; Strable, E.; Brown, S.; Manchester, M.; Finn, M. 
G. Plasma Clearance of Bacteriophage Qβ Particles as a Function of 
Surface Charge. J. Am. Chem. Soc. 2008, 130 (4), 1328–1334. 
 10 
(23)  Stephanopoulos, N.; Tong, G. J.; Hsiao, S. C.; Francis, M. B. Dual-Surface 
Modified Virus Capsids for Targeted Delivery of Photodynamic Agents to 
Cancer Cells. ACS Nano 2010, 4 (10), 6014–6020. 
(24)  Peeler, J. C.; Woodman, B. F.; Averick, S.; Miyake-Stoner, S. J.; Stokes, A. 
L.; Hess, K. R.; Matyjaszewski, K.; Mehl, R. A. Genetically Encoded 
Initiator for Polymer Growth from Proteins. J. Am. Chem. Soc. 2010, 132 
(39), 13575–13577. 
(25)  Teramoto, H.; Kojima, K. Production of Bombyx Mori Silk Fibroin 
Incorporated with Unnatural Amino Acids. Biomacromolecules 2014, 15 
(7), 2682–2690. 
(26)  Teramoto, H.; Amano, Y.; Iraha, F.; Kojima, K.; Ito, T.; Sakamoto, K. 
Genetic Code Expansion of the Silkworm Bombyx Mori to Functionalize 
Silk Fiber. ACS Synth. Biol. 2018, 7 (3), 801–806. 
(27)  Carrico, I. S.; Maskarinec, S. A.; Heilshorn, S. C.; Mock, M. L.; Liu, J. C.; 
Nowatzki, P. J.; Franck, C.; Ravichandran, G.; Tirrell, D. A. Lithographic 
Patterning of Photoreactive Cell-Adhesive Proteins. J. Am. Chem. Soc. 
2007, 129 (16), 4874–4875. 
(28)  Nowatzki, P. J.; Franck, C.; Maskarinec, S. A.; Ravichandran, G.; Tirrell, 
D. A. Mechanically Tunable Thin Films of Photosensitive Artificial 
Proteins: Preparation and Characterization by Nanoindentation. 
Macromolecules 2008, 41 (5), 1839–1845. 
(29)  Zhang, K.; Sugawara, A.; Tirrell, D. A. Generation of Surface-Bound 
Multicomponent Protein Gradients. ChemBioChem 2009, 10 (16), 2617–
2619. 
(30)  Hauf, M.; Richter, F.; Schneider, T.; Faidt, T.; Martins, B. M.; Baumann, 
T.; Durkin, P.; Dobbek, H.; Jacobs, K.; Möglich, A.; Budisa, N. 
Photoactivatable Mussel-Based Underwater Adhesive Proteins by an 
Expanded Genetic Code. ChemBioChem 2017, 18 (18), 1819–1823. 
(31)  Torculas, M.; Medina, J.; Xue, W.; Hu, X. Protein-Based Bioelectronics. 
ACS Biomater. Sci. Eng. 2016, 2 (8), 1211–1223. 
(32)  Panda, S. S.; Katz, H. E.; Tovar, J. D. Solid-State Electrical Applications of 
Protein and Peptide Based Nanomaterials. Chem. Soc. Rev. 2018, 47 (10), 
3640–3658. 
(33)  Wang, C.; Xia, K.; Zhang, Y.; Kaplan, D. L. Silk-Based Advanced 
Materials for Soft Electronics. Acc. Chem. Res. 2019, 52 (10), 2916–2927. 
(34)  Dickerson, M. B.; Sandhage, K. H.; Naik, R. R. Protein- and Peptide-
Directed Syntheses of Inorganic Materials. Chem. Rev. 2008, 108 (11), 
4935–4978. 
(35)  Hardy, J. G.; Scheibel, T. R. Composite Materials Based on Silk Proteins. 
Prog. Polym. Sci. 2010, 35 (9), 1093–1115. 
 11 
(36)  Calvaresi, M.; Zerbetto, F. The Devil and Holy Water: Protein and Carbon 
Nanotube Hybrids. Acc. Chem. Res. 2013, 46 (11), 2454–2463. 
(37)  Li, C.; Mezzenga, R. The Interplay between Carbon Nanomaterials and 
Amyloid Fibrils in Bio-Nanotechnology. Nanoscale 2013, 5 (14), 6207–
6218. 
(38)  Wang, F.; Yang, C.; Hu, X. Advanced Protein Composite Materials. ACS 
Symp. Ser. 2014, 1175, 177–208. 
(39)  Scheibel, T.; Parthasarathy, R.; Sawicki, G.; Lin, X. M.; Jaeger, H.; 
Lindquist, S. L. Conducting Nanowires Built by Controlled Self-Assembly 
of Amyloid Fibers and Selective Metal Deposition. Proc. Natl. Acad. Sci. 
U. S. A. 2003, 100 (8), 4527–4532. 
(40)  Sasso, L.; Suei, S.; Domigan, L.; Healy, J.; Nock, V.; Williams, M. A. K.; 
Gerrard, J. A. Versatile Multi-Functionalization of Protein Nanofibrils for 
Biosensor Applications. Nanoscale 2014, 6 (3), 1629–1634. 
(41)  Lin, Y.; Xia, X.; Wang, M.; Wang, Q.; An, B.; Tao, H.; Xu, Q.; Omenetto, 
F.; Kaplan, D. L. Genetically Programmable Thermoresponsive Plasmonic 
Gold/Silk-Elastin Protein Core/Shell Nanoparticles. Langmuir 2014, 30 
(15), 4406–4414. 
(42)  Guo, C.; Hall, G. N.; Addison, J. B.; Yarger, J. L. Gold Nanoparticle-
Doped Silk Film as Biocompatible SERS Substrate. RSC Adv. 2015, 5 (3), 
1937–1942. 
(43)  Das, C.; Krishnamoorthy, K. Flexible Microsupercapacitors Using Silk and 
Cotton Substrates. ACS Appl. Mater. Interfaces 2016, 8 (43), 29504–29510. 
(44)  Peng, Z.; Peralta, M. D. R.; Cox, D. L.; Toney, M. D. Bottom-up Synthesis 
of Protein-Based Nanomaterials from Engineered β-Solenoid Proteins. 
PLoS One 2020, 15 (2), 1–17. 
(45)  Flynn, C. E.; Lee, S. W.; Peelle, B. R.; Belcher, A. M. Viruses as Vehicles 
for Growth, Organization and Assembly of Materials. Acta Mater. 2003, 51 
(19), 5867–5880. 
(46)  Liu, Y.; Qi, N.; Song, T.; Jia, M.; Xia, Z.; Yuan, Z.; Yuan, W.; Zhang, K. 
Q.; Sun, B. Highly Flexible and Lightweight Organic Solar Cells on 
Biocompatible Silk Fibroin. ACS Appl. Mater. Interfaces 2014, 6 (23), 
20670–20675. 
(47)  Chen, A. Y.; Deng, Z.; Billings, A. N.; Seker, U. O. S.; Lu, M. Y.; Citorik, 
R. J.; Zakeri, B.; Lu, T. K. Synthesis and Patterning of Tunable Multiscale 
Materials with Engineered Cells. Nat. Mater. 2014, 13 (5), 515–523. 
(48)  Nguyen, P. Q.; Botyanszki, Z.; Tay, P. K. R.; Joshi, N. S. Programmable 
Biofilm-Based Materials from Engineered Curli Nanofibres. Nat. Commun. 
2014, 5, 1–10. 
(49)  Kalyoncu, E.; Ahan, R. E.; Olmez, T. T.; Safak Seker, U. O. Genetically 
 12 
Encoded Conductive Protein Nanofibers Secreted by Engineered Cells. 
RSC Adv. 2017, 7 (52), 32543–32551. 
(50)  Kang, M.; Jin, H. J. Electrically Conducting Electrospun Silk Membranes 
Fabricated by Adsorption of Carbon Nanotubes. Colloid Polym. Sci. 2007, 
285 (10), 1163–1167. 
(51)  Wang, E.; Desai, M. S.; Lee, S. W. Light-Controlled Graphene-Elastin 
Composite Hydrogel Actuators. Nano Lett. 2013, 13 (6), 2826–2830. 
(52)  Wang, E.; Desai, M. S.; Heo, K.; Lee, S. W. Graphene-Based Materials 
Functionalized with Elastin-like Polypeptides. Langmuir 2014, 30 (8), 
2223–2229. 
(53)  Liang, B.; Fang, L.; Hu, Y.; Yang, G.; Zhu, Q.; Ye, X. Fabrication and 
Application of Flexible Graphene Silk Composite Film Electrodes 
Decorated with Spiky Pt Nanospheres. Nanoscale 2014, 6 (8), 4264–4274. 
(54)  Annabi, N.; Shin, S. R.; Tamayol, A.; Miscuglio, M.; Bakooshli, M. A.; 
Assmann, A.; Mostafalu, P.; Sun, J. Y.; Mithieux, S.; Cheung, L.; Tang, 
X.; Weiss, A. S.; Khademhosseini, A. Highly Elastic and Conductive 
Human-Based Protein Hybrid Hydrogels. Adv. Mater. 2016, 28 (1), 40–49. 
(55)  Jeon, J. W.; Cho, S. Y.; Jeong, Y. J.; Shin, D. S.; Kim, N. R.; Yun, Y. S.; 
Kim, H. T.; Choi, S. B.; Hong, W. G.; Kim, H. J.; Jin, H. J.; Kim, B. H. 
Pyroprotein-Based Electronic Textiles with High Stability. Adv. Mater. 
2017, 29 (6), 1–6. 
(56)  Liu, Y.; Tao, L. Q.; Wang, D. Y.; Zhang, T. Y.; Yang, Y.; Ren, T. L. 
Flexible, Highly Sensitive Pressure Sensor with a Wide Range Based on 
Graphene-Silk Network Structure. Appl. Phys. Lett. 2017, 110 (12). 
(57)  Chi, N.; Wang, R. Electrospun Protein-CNT Composite Fibers and the 
Application in Fibroblast Stimulation. Biochem. Biophys. Res. Commun. 
2018, 504 (1), 211–217. 
(58)  Yin, Z.; Jian, M.; Wang, C.; Xia, K.; Liu, Z.; Wang, Q.; Zhang, M.; Liang, 
X.; Wang, H.; Liang, X.; Long, Y.; Yu, X.; Zhang, Y. Splash-Resistant and 
Light-Weight Silk-Sheathed Wires for Textile Electronics. Nano Lett. 2018, 
18 (11), 7085–7091. 
(59)  Cataldi, P.; Condurache, O.; Spirito, D.; Krahne, R.; Bayer, I. S.; 
Athanassiou, A.; Perotto, G. Keratin-Graphene Nanocomposite: 
Transformation of Waste Wool in Electronic Devices. ACS Sustain. Chem. 
Eng. 2019, 7 (14), 12544–12551. 
(60)  Herland, A.; Björk, P.; Nilsson, K. P. R.; Olsson, J. D. M.; Åsberg, P.; 
Konradsson, P.; Hammarström, P.; Inganäs, O. Electroactive Luminescent 
Self-Assembled Bio-Organic Nanowires: Integration of Semiconducting 
Oligoelectrolytes within Amyloidogenic Proteins. Adv. Mater. 2005, 17 
(12), 1466–1471. 
 13 
(61)  Hamedi, M.; Herland, A.; Karlsson, R. H.; Lnganäs, O. Electrochemical 
Devices Made from Conducting Nanowire Networks Self-Assembled from 
Amyloid Fibrils and Alkoxysulfonate PEDOT. Nano Lett. 2008, 8 (6), 
1736–1740. 
(62)  Müller, C.; Jansson, R.; Elfwing, A.; Askarieh, G.; Karlsson, R.; Hamedi, 
M.; Rising, A.; Johansson, J.; Inganäs, O.; Hedhammar, M. 
Functionalisation of Recombinant Spider Silk with Conjugated 
Polyelectrolytes. J. Mater. Chem. 2011, 21 (9), 2909–2915. 
(63)  Meier, C.; Lifincev, I.; Welland, M. E. Conducting Core-Shell Nanowires 
by Amyloid Nanofiber Templated Polymerization. Biomacromolecules 
2015, 16 (2), 558–563. 
(64)  Elfwing, A.; Bäcklund, F. G.; Musumeci, C.; Inganäs, O.; Solin, N. Protein 
Nanowires with Conductive Properties. J. Mater. Chem. C 2015, 3 (25), 
6499–6504. 
(65)  Bäcklund, F. G.; Elfwing, A.; Musumeci, C.; Ajjan, F.; Babenko, V.; 
Dzwolak, W.; Solin, N.; Inganäs, O. Conducting Microhelices from Self-
Assembly of Protein Fibrils. Soft Matter 2017, 13 (25), 4412–4417. 
(66)  Tsukada, S.; Nakashima, H.; Torimitsu, K. Conductive Polymer Combined 
Silk Fiber Bundle for Bioelectrical Signal Recording. PLoS One 2012, 7 
(4). 
(67)  Cai, N.; Wong, C. C.; Gong, Y. X.; Tan, S. C. W.; Chan, V.; Liao, K. 
Modulating Cell Adhesion Dynamics on Carbon Nanotube Monolayer 
Engineered with Extracellular Matrix Proteins. ACS Appl. Mater. 
Interfaces 2010, 2 (4), 1038–1047. 
(68)  Namgung, S.; Kim, T.; Baik, K. Y.; Lee, M.; Nam, J. M.; Hong, S. 
Fibronectin-Carbon-Nanotube Hybrid Nanostructures for Controlled Cell 
Growth. Small 2011, 7 (1), 56–61. 
(69)  Bongo, M.; Winther-Jensen, O.; Himmelberger, S.; Strakosas, X.; Ramuz, 
M.; Hama, A.; Stavrinidou, E.; Malliaras, G. G.; Salleo, A.; Winther-
Jensen, B.; Owens, R. M. PEDOT:Gelatin Composites Mediate Brain 
Endothelial Cell Adhesion. J. Mater. Chem. B 2013, 1 (31), 3860–3867. 
(70)  Kim, T.; Sridharan, I.; Zhu, B.; Orgel, J.; Wang, R. Effect of CNT on 
Collagen Fiber Structure, Stiffness Assembly Kinetics and Stem Cell 
Differentiation. Mater. Sci. Eng. C 2015, 49, 281–289. 
(71)  Radunovic, M.; De Colli, M.; De Marco, P.; Di Nisio, C.; Fontana, A.; 
Piattelli, A.; Cataldi, A.; Zara, S. Graphene Oxide Enrichment of Collagen 
Membranes Improves DPSCs Differentiation and Controls Inflammation 
Occurrence. J. Biomed. Mater. Res. - Part A 2017, 105 (8), 2312–2320. 
(72)  Ryan, A. J.; Kearney, C. J.; Shen, N.; Khan, U.; Kelly, A. G.; Probst, C.; 
Brauchle, E.; Biccai, S.; Garciarena, C. D.; Vega-Mayoral, V.; Loskill, P.; 
Kerrigan, S. W.; Kelly, D. J.; Schenke-Layland, K.; Coleman, J. N.; 
 14 
O’Brien, F. J. Electroconductive Biohybrid Collagen/Pristine Graphene 
Composite Biomaterials with Enhanced Biological Activity. Adv. Mater. 
2018, 30 (15), 1–8. 
(73)  Cui, X.; Lee, V. A.; Raphael, Y.; Wiler, J. A.; Hetke, J. F.; Anderson, D. J.; 
Martin, D. C. Surface Modification of Neural Recording Electrodes with 
Conducting Polymer/Biomolecule Blends. J. Biomed. Mater. Res. 2001, 56 
(2), 261–272. 
(74)  Zhang, L.; Stauffer, W. R.; Jane, E. P.; Sammak, P. J.; Cui, X. T. Enhanced 
Differentiation of Embryonic and Neural Stem Cells to Neuronal Fates on 
Laminin Peptides Doped Polypyrrole. Macromol. Biosci. 2010, 10 (12), 
1456–1464. 
(75)  Povlich, L. K.; Cho, J. C.; Leach, M. K.; Corey, J. M.; Kim, J.; Martin, D. 
C. Synthesis, Copolymerization and Peptide-Modification of Carboxylic 
Acid-Functionalized 3,4-Ethylenedioxythiophene (EDOTacid) for Neural 
Electrode Interfaces. Biochim. Biophys. Acta - Gen. Subj. 2013, 1830 (9), 
4288–4293. 
(76)  Maione, S.; Gil, A. M.; Fabregat, G.; Del Valle, L. J.; Triguero, J.; Laurent, 
A.; Jacquemin, D.; Estrany, F.; Jiménez, A. I.; Zanuy, D.; Cativiela, C.; 
Alemán, C. Electroactive Polymer-Peptide Conjugates for Adhesive 
Biointerfaces. Biomater. Sci. 2015, 3 (10), 1395–1405. 
(77)  Cui, X.; Wiler, J.; Dzaman, M.; Altschuler, R. A.; Martin, D. C. In Vivo 
Studies of Polypyrrole/Peptide Coated Neural Probes. Biomaterials 2003, 
24 (5), 777–787. 
(78)  Zhu, B.; Luo, S. C.; Zhao, H.; Lin, H. A.; Sekine, J.; Nakao, A.; Chen, C.; 
Yamashita, Y.; Yu, H. H. Large Enhancement in Neurite Outgrowth on a 
Cell Membrane-Mimicking Conducting Polymer. Nat. Commun. 2014, 5 
(May), 1–9. 
(79)  Khatayevich, D.; Page, T.; Gresswell, C.; Hayamizu, Y.; Grady, W.; 
Sarikaya, M. Selective Detection of Target Proteins by Peptide-Enabled 
Graphene Biosensor. Small 2014, 10 (8), 1505–1513. 
(80)  Tara Bahadur, K. C.; Tada, S.; Zhu, L.; Uzawa, T.; Minagawa, N.; Luo, S. 
C.; Zhao, H.; Yu, H. H.; Aigaki, T.; Ito, Y. In Vitro Selection of 
Electrochemical Peptide Probes Using Bioorthogonal TRNA for Influenza 
Virus Detection. Chem. Commun. 2018, 54 (41), 5201–5204. 
(81)  Lee, K.; Yoo, Y. K.; Chae, M. S.; Hwang, K. S.; Lee, J.; Kim, H.; Hur, D.; 
Lee, J. H. Highly Selective Reduced Graphene Oxide (RGO) Sensor Based 
on a Peptide Aptamer Receptor for Detecting Explosives. Sci. Rep. 2019, 9 
(1), 1–9. 
(82)  Li, W.; Gao, Y.; Zhang, J.; Wang, X.; Yin, F.; Li, Z.; Zhang, M. Universal 
DNA Detection Realized by Peptide Based Carbon Nanotube Biosensors. 
Nanoscale Adv. 2020, 2 (2), 717–723. 
 15 
(83)  Lebaron, R. G.; Athanasiou, K. A. Extracellular Matrix Cell Adhesion 
Peptides: Functional Applications in Orthopedic Materials. Tissue Eng. 
2000, 6 (2), 85–103. 
(84)  Waugh, D. S. Making the Most of Affinity Tags. Trends Biotechnol. 2005, 
23 (6), 316–320. 
(85)  Zhao, X.; Li, G.; Liang, S. Several Affinity Tags Commonly Used in 







C h a p t e r  2  
INCORPORATION OF EDOT-ALA INTO PROTEINS 
2.1. Abstract 
Poly(3,4-ethylenedioxythiophene) is a π-conjugated polymer that exhibits high electrical 
conductivity, electrochemical stability, and biocompatibility, and therefore, is applied in 
various fields including bioelectronics. We envisioned that genetic incorporation of the 
monomer precursor of PEDOT will facilitate the fabrication of protein-based conductive 
materials. To this end, we sought to genetically incorporate an ncAA bearing EDOT group 
by harnessing E. coli protein biosynthesis machinery. We prepared an amino acid EDOT-
Ala in three steps of organic reaction. To incorporate EDOT-Ala into proteins, we 
examined the activity of known aaRS variants such as an endogenous E. coli TrpRS, yeast 
PheRS(T415G), and MmPylRS(N346A/C348A), which were previously reported to 
activate bulky amino acids. However, we were unable to find any aaRS variant that 
recognizes EDOT-Ala. We then performed evolution of MmPylRS(N346A/C348A) and p-
NFRS to alter their specificity towards EDOT-Ala via two approaches: cell viability-based 
evolution and phage-assisted evolution. Unfortunately, neither of these strategies yielded an 
aaRS that incorporates EDOT-Ala. We believe that a broader search of aaRS and further 









Protein-based materials are attractive candidates for applications in bioelectronics. In order 
to introduce electrical conductivity into protein-based materials, electrical conductors such 
as metals, carbon-based materials, and conductive polymers are often combined with 
proteins to create conductive biohybrid materials.1–6 We envisioned that genetic 
incorporation of an electroactive functional group into proteins could be used to form a 
protein–conductive polymer conjugate and will provide a new strategy to produce protein-
based conductive materials. To this end, we prepared a non-canonical amino acid (ncAA) 
bearing 3,4-ethylenedioxythiophene (EDOT) and performed incorporation into proteins. 
EDOT is the monomer precursor of the conductive polymer PEDOT, which is recognized 
as the most successful conductive polymer in both fundamental research and practical 
applications.7–12 Due to its attractive features such as high conductivity, electrochemical 
stability, and biocompatibility, PEDOT has been used for various bioelectronics 
applications such as tissue engineering,13–18 neural probes,19–22 biosensors,9,23–27 and drug 
delivery.28–30 
The key requirement for incorporation of an ncAA is an aminoacyl-tRNA synthetase 
(aaRS) that can recognize the target ncAA and ligate it to the cognate tRNA.31–33 Because 
of this requirement, ncAAs are usually designed as analogues of canonical amino acids or 
previously reported ncAAs, and the aaRS variants for the known amino acids are used as 
an initial set of aaRSs to evaluate their activities for the target ncAA. When the tested aaRS 
variants show little or no activity for the target ncAA, new aaRS variants should be 
prepared by mutagenesis. Directed evolution34–36 and rational and computational design37–
42 are effective approaches to alter the specificity of aaRS towards target ncAAs. 
The EDOT group consists of bulky functional groups such as a thiophene ring and a 
dioxane ring. Therefore, aaRS with a large binding pocket should be used to incorporate 
the ncAA bearing an EDOT group.  A major class of bulky amino acids is derivatives of 
phenylalanine (Phe). Besides the canonical amino acid Tyrosine (Tyr), a large number of 
substituted Phe analogues have been successfully incorporated by phenylalanyl t-RNA 
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synthetase (PheRS),37,43 tyrosyl t-RNA synthetase (TyrRS),44 and pyrrolysyl t-RNA 
synthetase (PylRS)44,45 derived from different organisms. 
Here, we designed an amino acid with the EDOT group (designated EDOT-Ala) as an 
analogue of aromatic canonical amino acids and sought to incorporate the ncAA using 
aaRS variants with large binding pockets. We performed evolution of the aaRS by two 
different evolution approaches: cell viability-based method34,35 and phage-assisted 
method.36 Although EDOT-Ala was not incorporated by evolved aaRS variants, the results 
presented in this chapter provide valuable insights into incorporation of EDOT-
functionalized amino acids into proteins. 
2.3. Results and Discussion 
2.3.1. Synthesis of an amino acid EDOT-Ala 
We synthesized an ncAA bearing the EDOT group termed EDOT-Ala (Figure 2.1). In 
EDOT-Ala, the dioxane ring of EDOT lies one methylene group apart from the α-carbon, 
which is the same position as the indole group of Trp and the phenol group of Tyr and Phe 
(Figure 2.1). Based on the structural similarity of EDOT-Ala and these large natural amino 
acids, we hypothesized that EDOT-Ala is recognized by endogenous or engineered aaRSs 
for these amino acids. Kwon et al. have demonstrated that an engineered yeast PheRS 
(yPheRS(T415G)) efficiently incorporates Trp analogues at the amber stop codon when co-
expressed with a mutant yeast phenylalanine amber suppressor tRNA (ytRNAPheCUA_UG).43 
Moreover, the Phe analogues with various substituents have also been incorporated using a 
TyrRS/tRNA pair from the archaebacteria Methanococcus jannaschii 
(MjTyrRS/tRNATyrCUA) and PylRS/tRNA pairs from Methanosarcina mazei 
(MmPylRS/tRNAPylCUA) and Methanosarcina barkeri (MbPylRS/tRNAPylCUA).44 In 
addition to the existence of aaRS variants that activate bulky amino acids, previous studies 
have proven that active aaRS for target ncAAs can be produced by directed evolution34–36 
and rational and computational design.37–42 Therefore, we envisioned that EDOT-Ala 




Figure 2.1. Chemical structures of EDOT-Ala and natural amino acids Trp, Tyr, and Phe. 
The synthetic scheme of EDOT-Ala is shown in Figure 2.2. EDOT-Ala was synthesized 
via alkylation of N-(diphenylmethylene)glycine ethyl ester (1) and subsequent deprotection 
of the Schiff base under acidic conditions.46 A diphenylmethylene protecting group was 
employed because the deprotection proceeds rapidly at room temperature.46 The choice of 
the protecting group was critical for the synthesis of EDOT-Ala, because the EDOT group 
is susceptible to harsh acidic conditions. The synthesis was completed in three steps from 
the commercial compounds, and EDOT-Ala was obtained as a racemic mixture with a 
relatively good yield. Because previous studies have demonstrated the successful 
incorporation of ncAAs regardless of the use of a racemic mixture,47,48 we proceeded to the 
incorporation experiment without isolation of the L-type of EDOT-Ala. The details of the 
synthesis and NMR data are provided in Section 2.4.2 and 2.6. 
 
Figure 2.2. Synthesis of EDOT-Ala.  
2.3.2. Incorporation of EDOT-Ala Using Known aaRS Variants 
Natural TrpRS has a large binding pocket to accommodate the bulky amino acid Trp, 
which carries an indole group in the side chain. Therefore, we anticipated that endogenous 
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E. coli TrpRS should be able to recognize EDOT-Ala. To test this possibility, we 
performed incorporation of EDOT-Ala via the global replacement approach. We chose an 
artificial coiled coil protein SYNZYP349 as a test protein, which carries no Trp residue in 
the main sequence. We prepared a plasmid encoding a single Trp residue at position 4, a 
copy of SYNZYP3, and N- and C-terminal 6xHisTags for affinity purification (Figure 2.3a). 
The test protein was placed under the control of bacteriophage T5 promoter to enable 
induction by isopropyl-β-Dthiogalactopyranoside (IPTG). 
We expressed SYNZIP3 in a Trp-auxotrophic E. coli strain derived from DH10B. After 
culturing the cells to the mid-log phase in M9 minimal media supplemented with 20 
canonical amino acids, the media was shifted to M9 media supplemented with 2 mM 
EDOT-Ala and 19 amino acids without Trp, and expression was induced for 5 hours by 
addition of IPTG. Then cells were lysed, and the protein was purified by Ni-NTA 
chromatography and subjected to SDS-PAGE. Unfortunately, no bands corresponding to 
SYNZIP3 appeared for the sample expressed in the presence of EDOT-Ala, whereas the 
positive control expressed in the presence of Trp showed the bands for SYNZIP3. 
 
Figure 2.3. Incorporation of EDOT-Ala by endogenous E. coli TrpRS. (a) Sequence of SYNZIP3 
with a single Trp codon. (b) Coomassie-stained SDS-PAGE for purified proteins. Proteins were 
expressed in M9 minimal media supplemented with (i) 19 canonical amino acids (no Trp) with 
EDOT-Ala and (ii) 20 canonical amino acids. M: marker. 
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Next, we investigated the activity of an engineered yeast PheRS (yPheRS(T415G)) that 
was previously reported to activate Phe and Trp analogues (p-bromophenylalanine (pBrF), 
6-chlorotryptophan (6ClW), 6-bromotryptophan (6BrW), and benzothienylalanine (BT)).43  
The pair of yPheRS(T415G) and a mutant yeast phenylalanine amber suppressor tRNA 
(ytRNAPheCUA_UG) is orthogonal to the endogenous E. coli translational apparatus, and 
introduction of the pair into an E. coli expression host allowed site-specific incorporation of 
the analogues at amber stop codons with high fidelity.43 Therefore, we anticipated that the 
yPheRS(T415G)/ytRNAPheCUA_UG pair could be used to incorporate EDOT-Ala. 
To study this possibility, we expressed recombinant murine dihydrofolate reductase 
(mDHFR) as a test protein following a previously reported procedure.43 We used a Phe/Trp 
double auxotrophic strain of E. coli as a host cell and performed expression in M9 minimal 
media supplemented with 18 amino acids (40 mg/L), low concentrations of Phe (0.03 mM) 
and Trp (0.01 mM), and 3 mM EDOT-Ala. After expression, cells were lysed and 
subjected to SDS-PAGE. We observed the protein bands corresponding to the mDHFR in 
all induced samples. (Figure 2.4). However, the sample expressed in the presence of 
EDOT-Ala only showed a faint band comparable to the negative control expressed in the 
presence of 5-bromotryptophan (5BrW). Because the previous study indicated that 5BrW is 
not recognized by the yPheRS(T415G) and that Phe predominantly occupies the amber 
codon under this experimental condition, it is unlikely that yPheRS(T415G) has high 
activity for EDOT-Ala. Although there is a possibility that some portion of the expressed 
protein contained EDOT-Ala, we did not further investigate the product by mass 
spectrometry in order to conserve the amino acid from a large-scale expression and 
proceeded to explore other aaRS variants. 
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Figure 2.4. Incorporation of EDOT-Ala by the yPheRS(T415G) into mDHFR. Coomassie-
stained SDS-PAGE of (i) uninduced culture and induced cultures in M9 minimal media 
supplemented with (ii) 20 canonical amino acids (40 mg/L), (iii) 18 amino acids (40 mg/L), Phe 
(0.03 mM), Trp (0.01 mM), 5-BrTrp (1 mM), and (iv) 18 amino acids (40 mg/L), Phe (0.03 mM), 
Trp (0.01 mM), and EDOT-Ala (3 mM). M: marker. 
The variants of aaRS from methanogenic archaea, MjTyrRS, MmPylRS, and MbPylRS 
have been used for site-specific incorporation of a variety of amino acids via amber 
suppression. In particular, MmPylRS(N346A/C348A) developed by Liu et al. facilitated 
efficient incorporation of various Phe derivatives in E. coli host cells.50–53 Therefore, we 
investigated the activity of MmPylRS(N346A/C348A) to incorporate EDOT-Ala. 
We chose green fluorescent protein (GFP) as a test protein, which enables evaluation of the 
aaRS activity based on cellular fluorescence. To avoid potential complications arising from 
the disturbance of fluorescent activity of GFP by incorporation of EDOT-Ala, we placed an 
amber codon upstream of the main GFP sequence (GFP-S4am; Figure 2.5a). Incorporation 
was performed in the BL21(DE3) strain of E. coli cells expressing the 
MmPylRS(N346A/C348A)/tRNAPyl pair. The cells were cultured in 2xYT media 
supplemented with 2 mM EDOT-Ala, induced for 18 hours, and subjected to flow 
cytometry. For comparison, we also prepared the uninduced cells and induced cells without 
ncAA or with one of the Phe analogues previously reported to be recognized by 
MmPylRS(N346A/C348A).51 In the previous study, three Phe analogues, 3-
trifluoromethylphenylalanine (3-CF3F), 3-chlorophenylalanine (3-ClF), and 3-
cyanophenylalanine (3-CNF), yielded 39, 16, and 7 mg of a superfolder GFP (sfGFP) per 
one litter scale of E. coli culture in modified glycerol minimal media.51 In our flow 
cytometry experiment, the induced cells cultured with EDOT-Ala showed a significantly 
larger median fluorescence than uninduced cells (Figure 2.5b). However, the distribution of 
the cell population was very similar to those of the cells cultured without ncAA or with 3-
cyanophenylalanine (3-CNF). These results imply that the observed fluorescence from the 
cells cultured with EDOT-Ala could originate from background fluorescence due to the 
incorporation of canonical amino acids such as Phe and Tyr. 
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To avoid the mis-incorporation of Phe and Tyr, we performed GFP expression in M9 
minimal media without supplementing these amino acids. The resulting cells showed 
significantly less background fluorescence than the cells expressed in 2xYT (Figure 2.5c). 
However, the median fluorescence in the cells cultured with EDOT-Ala was only slightly 
larger than those cultured without ncAA. When we analyzed the purified protein by mass 
spectrometry, the GFP expressed in the presence of EDOT-Ala showed a predominant peak 
corresponding to the incorporation of Tyr at the amber codon, and no peak for GFP with 
EDOT-Ala was observed (data not shown). This is attributed to the endogenous production 
of Tyr by the BL21(DE3) strain of E. coli cells. Although we attempted to express GFP 
using a Phe/Tyr double auxotrophic strain of E. coli, the cell growth in M9 minimal media 
without Phe and Tyr was significantly hindered, and the protein was not expressed well. 
 
Figure 2.5. Incorporation of EDOT-Ala by MmPylRS(N346A/C348A). (a) Sequence of the GFP 
reporter protein (GFP-S4am). (b) Flow cytometry analysis of GFP expression in E. coli host cells 
cultured in 2xYT media. (i) Uninduced (red), (ii) no ncAA (green), (iii) EDOT-Ala (blue), (iv) 
3CF3F (magenta), (v) 3-ClF (orange), and (vi) 3-CNF (aqua). (c) Flow cytometry analysis of GFP 
expression in E. coli host cells cultured in M9 minimal media supplemented with 18 canonical 
amino acids without Phe and Tyr. (i) Uninduced (red), (ii) no ncAA (green), (iii) EDOT-Ala (blue), 




2.3.3. Evolution of aaRS by Cell Viability-Based Selection 
Because we were unable to incorporate EDOT-Ala using the known aaRSs such as an 
endogenous E. coli TrpRS, yeast PheRS(T415G), and MmPylRS(N346A/C348A), we next 
sought to develop aaRS by directed evolution. Protein evolution has been proven to be a 
powerful tool to create aaRS variants for target ncAAs.34–36 One of the major approaches 
utilizes positive and negative selections based on cell viability upon expression of an 
antibiotic resistance gene and a bacterial toxin.34,35 The positive selection plasmid encodes 
a chloramphenicol acetyltransferase (CAT) gene under constitutive promoter, which 
confers the resistance to an antibiotic chloramphenicol (Figure 2.6a).35 Because an amber 
codon is placed in the middle of the CAT gene, the plasmid confers resistance to 
chloramphenicol only when an amino acid is incorporated at the amber codon. Thus, the 
plasmid allows viability-based screening of the cells carrying the aaRS gene that activates 
the target ncAA. The negative selection plasmid encodes a bacterial toxin barnase with two 
amber codons (Figure 2.6b).34 When the aaRS has off-target activity towards canonical 
amino acids, barnase is expressed and exerts lethal effect to the host E. coli cells. Following 
these established screening methods, we sought to create an aaRS that is capable of 
incorporating EDOT-Ala. 
 
Figure 2.6. Evolution of MmPylRS(N346A/C348A) for incorporation of EDOT-Ala. Plasmids used 
for (a) positive and (b) negative selection of active aaRS variants. (c) Crystal structure of the active 
site of MmPylRS. Adapted from ref. 50. 
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We chose MmPylRS(N346A/C348A) as a template for evolution because of its ability to 
incorporate various Phe analogues.50–53 The plasmid toolset was readily available for 
evolution of MmPylRS variants, and no laborious cloning was required to customize the 
plasmids to perform experiments. Although this template itself did not show any activity 
towards EDOT-Ala (see 2.3.2. Incorporation of EDOT-Ala using known aaRS variants), 
we reasoned that mutations at the active site would alter the specificity to enable 
incorporation of EDOT-Ala. 
To this end, we constructed a site-saturation mutagenesis library of 
MmPylRS(N346A/C348A) targeting the five residues at the amino acid binding pocket: 
L305, Y306, L309, Y384, and W417 (Figure 2.6). These residues were previously targeted 
to alter the specificity of MmPylRS variants.54,55 The plasmid library was transformed into 
E. coli cells harboring the positive selection plasmid encoding chloramphenicol 
acetyltransferase (CAT) gene with an amber codon at position 112. The transformed cells 
were grown overnight on LB agar plates supplemented with chloramphenicol and EDOT-
Ala. Over 100 colonies were formed in 72 hours, and we collected 62 colonies to extract 
plasmids. The plasmids were transformed into E. coli cells harboring the negative selection 
plasmid encoding a toxic protein barnase with amber codons at positions 2 and 44. When 
the cells were grown on LB agar plates without EDOT-Ala, 8 colonies appeared after 18 
hours. We collected the colonies, extracted plasmids, and subjected them to another cycle 
of positive selection. We did not observe any colony formation in 72 hours. Therefore, it is 
likely that the survived population in the first positive selection was due to the mutation of 
amber codon to sense codon in CAT gene or degradation of chloramphenicol over the long 
culture time. The other possible explanation is that the aaRS variants have low off-target 
activity and the cells were able to survive in the negative selection. Future steps in this 
experiment would be the optimization of selection stringency based on concentration of 
EDOT-Ala and number of amber codons in positive and negative selection plasmids as 
well as targeting a broader range of residues in MmPylRS(N346A/C348A). 
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2.3.4. Evolution of aaRS by Phage-Assisted Approach  
Recently, a novel evolution technique has been developed by Liu et al. using an engineered 
M13 bacteriophage.36,56 This technique, termed phage-assisted continuous evolution 
(PACE) or non-continuous evolution (PANCE), enabled the production of highly active 
and selective aaRSs for their target ncAAs.36 We reasoned that the technique could be used 
to create an aaRS variant that recognizes EDOT-Ala. 
 
Figure 2.7. Phage-assisted protein evolution. M: mutagenesis plasmid, A: accessory plasmid, S: 
selection phage. 
The general scheme of phage-assisted evolution is described in Figure 2.7. Phage-assisted 
evolution utilizes propagation of an engineered M13 bacteriophage termed selection phage 
(SP). In each evolution cycle, SP is allowed to propagate based on the activity of aaRS and 
diluted for the next cycle. SP carries the gene of aaRS replacing a phage gene gIII, which 
encodes an essential protein (pIII) required for the progeny phage infectivity. Due to the 
lack of gIII, SP does not propagate by itself. Instead, E. coli cells harboring an accessory 
plasmid coding gIII are used to assist the propagation of SP. To link the activity of aaRS 
and phage propagation, expression of pIII is regulated by the event of amber suppression. 
In low stringency strategy, amber codons are placed in T7 RNA polymerase (T7 RNAP) 
coded on the complementary plasmid (CP), and gIII is placed under control of T7 promoter 
on the accessory plasmid (AP) (Figure 2.8a). This way, expression of one copy of T7 
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RNAP can produce multiple pIII to impart infectivity to SP. In the high stringency 
strategy, amber codons are placed directly in gIII encoded on AP (Figure 2.8b). Therefore, 
expression of a copy of pIII requires multiple events of amber suppression to provide high 
stringency in the selection. 
 
Figure 2.8. Design of plasmids used for positive selections in phage-assisted evolution. (a) Low 
stringency selection and (b) high stringency selection. MP: mutagenesis plasmid, AP: accessory 
plasmid, CP: complementary plasmid. Psp: phage-shock promoter. 
Library diversity of aaRS is generated in vivo using the mutagenesis plasmid (MP).36,57 MP 
encodes dnaQ926 (dominant-negative variant of the E. coli DNA Pol III proofreading 
domain), dam (DNA adenine methylase that impairs mismatch repair), and seqA (negative 
regulator of DNA replication), which elevate the error rate during DNA replication with 
minimal background mutations under the uninduced condition. By combining MP-induced 
in vivo mutagenesis and SP-based selection for active aaRS, aaRS variants with high 
activity towards the target ncAA are enriched without laborious cloning steps between 
evolution cycles.36 
Negative selection relies on the production of a dominant-negative variant of pIII termed 
pIII-neg (Figure 2.9a).58 Because pIII-neg impairs the infectivity of the emergent phage, 
propagation of SP is hindered. To link the activity of aaRS with expression of pIII-neg, the 
gene of pIII-neg is placed under control of T7 promoter on CP, and T7 RNAP with amber 
codons is coded on AP (Figure 2.9b). 
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Figure 2.9. Negative selection in phage-assisted evolution. (a) SP carrying pIII-neg shows 
attenuated infectivity. (b) Design of plasmids for negative selection. 
To develop an aaRS for EDOT-Ala, we performed phage-assisted evolution using a mutant 
MjTyrRS (p-NFRS) as a template. p-NFRS was originally evolved from MjTyrRS for 
incorporation of p-nitrophenylalanine (p-NF),59 but has activity towards Phe and p-
iodophenylalanine (p-IF).36 A previous study demonstrated that phage-assisted evolution of 
p-NFRS significantly enhanced its activity and specificity towards p-IF.36 Because 
MjTyrRS mutants are widely used to incorporate various Phe derivatives, we reasoned that 
phage-assisted evolution of p-NFRS can produce an aaRS that recognizes EDOT-Ala. 
We performed 8 positive selection cycles in 2xYT media supplemented with EDOT-Ala, 
increasing stringency after several cycles (Phase 1) (Figure 2.10a). The phage titer 
significantly decreased after the initial cycle, which is attributed to the limited diversity and 
low activity of aaRS library. The phage titer increased over the subsequent positive 
selection cycles and decreased when the selection stringency was increased. Selection was 
continued to Phase 2 alternating three negative selection cycles and two positive selection 
cycles (Figure 2.10b). We observed a decreased phage titer after switching to positive or 
negative selections. Six plaques were sequenced at each cycle to trace the evolution of p-
NFRS. At the early stage of the evolution, we observed no mutation or several mutations in 
each sample, and none of the samples shared common mutations (Figure 2.10c). At the late 
stage of the evolution, we found two converged mutations in all six samples: L110F and 
A167T. These residues are located in close proximity to the binding pocket of MjTyrRS 
(Figure 2.11a), and A167 was previously reported to affect the activity of MjTyrRS.42,60,61 
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Figure 2.10. Evolution of p-NFRS for EDOT-Ala in 2xYT. (a, b) Change in the phage titer in (a) 
Phase 1: eight positive selection cycles of batch 1 (blue) and batch 2 (red), and (b) Phase 2: fourteen 
positive and negative selection cycles of batch 1 (green) and batch 2 (magenta). Three negative 
cycles and two positive cycles were alternated. The type of APs used for the selection are indicated 
above the graphs. (* indicates the number of amber codons.) Starting SP solutions for phase 2 are 
indicated by dot lines.  (c) Mutations in aaRS found in cycle 3 of batch 1 in phase1 (left) and cycle 
14 of batch 1 in phase 2. 
To determine whether EDOT-Ala is activated by this mutant, we cloned p-
NFRS(L110F/A167T) into a plasmid and co-expressed in E. coli with GFP bearing an 
amber codon at position 4 (Figure 2.11b). After induction for 16 hours, the cells cultured in 
2xYT with EDOT-Ala exhibited strong fluorescence. However, the cells cultured without 
ncAA also showed fluorescence at the comparable level. This result indicates that p-
NFRS(L110F/A167T) has high off-target activity towards canonical amino acids. 
 
Figure 2.11. Crystal structure of MjTyrRS mutant (PDB: 4PBR) highlighting the active site 
residues and its substrate 4-(2’-bromoisobutyramido)-phenylalanine (BibaF). (b) Fluorescence 
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measurement of the cells co-expressing p-NFRS(L110F/A167T) and GFP-4am. (i) Uninduced, 
(ii) no ncAA, (iii) EDOT-Ala. 
To minimize the possibility that the aaRSs gain the off-target activity towards canonical 
amino acids, we proceeded the evolution in M9 minimal media supplemented with 17 
amino acids (no Phe, Tyr, Trp) and EDOT-Ala. We performed a total of 17 evolutions, 
starting with 6 successive positive selection cycles and then alternating 3 negative selection 
cycles and 2 positive selection cycles (Figure 2.12a). Over the course of evolution, we 
observed the convergence in mutations in the sequence of aaRS (Figure 2.12c). We chose 
four aaRS variants from different cycles of evolution and analyzed their activity by co-
expression with GFP bearing an amber codon at position 4. Unfortunately, all the variants 
showed strong background fluorescence in the absence of EDOT-Ala (Figure 2.12b). The 
mass peaks of all the purified proteins corresponded with the incorporation of Tyr at the 
amber codon. We also performed a phage-assisted evolution using another template 
MmPylRS(N346A/N348C), but the evolved mutants acquired off-target activity towards 
canonical amino acids and did not incorporate EDOT-Ala (data not shown). 
The major challenge in the phage-assisted evolution for EDOT-Ala was the evolution of 
aaRS to acquire off-target activity for canonical amino acids. Because initial templates had 
little or no activity for EDOT-Ala, it was especially difficult to evolve the aaRS to target 
EDOT-Ala in the presence of other amino acids to compete with. To circumvent this 
problem, future experiments should start with cycles without selection pressure to generate 
a diverse aaRS library. Another approach could be to construct a site-saturation 
mutagenesis library of SP by targeting key residues of aaRS and start selection cycles with 
the diversified library. These approaches will allow a broader search of aaRS mutants and 
increase the probability to generate an aaRS variant for EDOT-Ala.   
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Figure 2.12. Evolution of p-NFRS for EDOT-Ala in M9 minimal media supplemented with 17 
canonical amino acids (no Phe, Tyr, Trp) and EDOT-Ala (Phase 3). (a) Changes in the phage titer 
during six positive selection cycles followed by alternating negative and positive cycles. Three 
negative cycles and two positive cycles were alternated. Low stringency method was used for 
positive selection. SP solutions from cycle 3 of batch 1 in phase 1 and cycle 14 of batch 1 in phase 2 
were used as starting SP libraries. (b) Fluorescence measurement of the cells co-expressing p-NFRS 
mutants and GFP-4am. Uninduced (red), no ncAA (blue), EDOT-Ala (magenta). Mutations in each 
variant are indicated in (c). (c) Common mutations found during evolution cycles. * indicates the 
amino acid incorporated at amber codon analyzed by ESI-MS after protein purification. 
2.3.5. Discussion 
We initially hypothesized that EDOT-Ala should be incorporated by one of the aaRS 
variants that recognizes the analogues of Phe, Tyr, and Trp due to the structural similarity 
between EDOT-Ala and these analogues. However, we were unable to find aaRS variants 
for EDOT-Ala through testing the activity of known aaRS and through their evolution. One 
critical difference between EDOT-Ala and these analogues would be that EDOT-Ala 
carries a non-planar dioxane ring whereas Phe, Tyr, and Trp carry an aromatic ring that can 
form π–stacking interactions with the residues of aaRS. Although various ncAAs have been 
incorporated using PheRS, TyrRS, and PylRS from different species, many of them carry 
an aromatic ring at the same position as Phe, Tyr, and Trp. Major exceptions are analogues 
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of Pyl, which carry longer side chains than Phe, Tyr, and Trp. Various Pyl analogues 
with large substituents have been incorporated using engineered PylRS, and therefore, we 
investigated the incorporation of EDOT-functionalized Pyl analogue in the next chapter. 
2.4. Conclusion 
Novel ncAA, EDOT-Ala was synthesized in three steps from commercial compounds. We 
sought to genetically incorporate EDOT-Ala using the known aaRS variants that have 
activity towards bulky amino acids (i.e. endogenous E. coli TrpRS, yPheRS(T415G), 
MmPylRS(N346A/C348A)), but these variants did not show activity for EDOT-Ala. We 
then performed evolution of aaRS variants via cell viability-based selection and phage-
assisted evolution. However, the selected mutants showed large off-target activity for 
canonical amino acids and did not incorporate EDOT-Ala. For future experiments, we 
propose to perform evolution with a more diverse aaRS library as a starting point, which 
increases the probability to generate aaRS for EDOT-Ala. 
2.5. Experimental Procedures 
2.5.1. General 
All the reagents for organic synthesis were purchased from Sigma Aldrich and Tokyo 
Chemical Industry Co., Ltd. (TCI), and used as received without further purification. For 
column chromatography, Biotage Isolera Spektra equipped with a SNAP HP-Sil 10 g 
cartridge or a SNAP ULTRA C18 12 g cartridge was used. 1H (500 MHz) and 13C NMR 
(126 MHz) spectra were recorded on a Varian Inova 500 spectrometer. Analytical HPLC 
analyses for small compounds were performed with an Agilent 1290 Infinity Series HPLC 
instrument at the Center for Catalysis and Chemical Synthesis in the Caltech Beckman 
Institute.	 High-resolution mass spectrometry (HRMS) was performed with an LCT Premier 
XE Electrospray TOF Mass Spectrometer with electrospray ionization (ESI) at the Caltech 
CCE Multiuser Mass Spectrometry Laboratory. Matrix-assisted laser desorption/ionization 
time-of-flight mass (MALDI-TOF MS) spectrometry measurements were carried out on a 
Bruker Daltonics autoflexTM speed MALDI-TOF/TOF spectrometer at the Caltech CCE 
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Multiuser Mass Spectrometry Laboratory. A Tecan Safire II plate reader was used for the 
fluorescence measurement in 96-well plates. 
2.5.2. Synthesis and Characterization of Compounds 
 
Iodomethyl EDOT (2). Chloromethyl EDOT (1) (1.20 g, 6.32 mmol) and sodium iodide 
(6.62 g, 44.2 mmol) were dissolved in anhydrous DMF (15 mL) under Ar atmosphere. 
The reaction mixture was heated to 100 ºC and stirred for 4 h. After cooling to room 
temperature, water (50 mL) was added and the reaction was extracted with DCM (3 x 20 
mL). The combined organic layers were dried over MgSO4, and concentrated in vacuo, 
yielding 1.7 g (98%) of a white solid. 1H NMR (500 MHz, CDCl3) δ 6.37 (d, J = 3.7 Hz, 
1H), 6.36 (d, J = 3.7 Hz, 1H), 4.31 (dd, J = 11.5, 2.1 Hz, 1H), 4.28 – 4.23 (m, 1H), 4.15 
(dd, J = 11.6, 6.2 Hz, 1H), 3.37 – 3.29 (m, 2H).; 13C NMR (126 MHz, CDCl3) δ 141.17, 
140.89, 100.23, 100.12, 72.96, 67.40, 0.83. HRMS (ESI) calculated for C7H7IO2S 
[M+H]+: m/z = 282.9290; found: 282.9307.  
 
N-(Diphenylmethylene)-EDOT-Ala-ethyl ester (4). N-(Diphenylmethylene)glycine 
ethyl ester (3) (1.37 g, 4.25 mmol) was dissolved in anhydrous toluene (4 mL) under Ar 
atmosphere. Sodium hydride (60% dispersion in mineral oil, 170 mg, 4.25 mmol) was 
added, and the reaction mixture was stirred at room temperature for 1 h. Iodomethyl 
EDOT (1.00 g, 3.54 mmol) was dissolved in anhydrous THF (4 mL) and slowly added to 
the reaction mixture. The solution was stirred at room temperature for 20 h. A small 
amount of ethanol was added to quench unreacted sodium hydride. Water (50 mL) was 
added and the reaction was extracted with DCM (3 x 20 mL). The combined organic 
layers were dried over MgSO4, and concentrated in vacuo, yielding 580 mg (39%) of a 
white solid. 1H NMR (500 MHz, CDCl3) δ 7.64-7.16 (m, 10H), 6.28 (dd, J = 3.7, 0.8 Hz, 
1H), 6.16-6.11 (dd, J = 3.6, 0.8 Hz, 1H), 5.30 (d, J = 0.8 Hz, 1H), 4.47-3.83 (m, 5H), 
2.25 (m, 2H), 1.27 (m, 3H); 13C NMR (126 MHz, CDCl3) δ 196.93, 172.61, 141.69, 
132.57, 130.21, 129.04, 128.98, 128.88, 128.77, 128.65, 128.42, 128.40, 128.26, 128.19, 
126.67, 99.55, 99.47, 70.34, 68.69, 68.19, 61.40, 60.97, 34.03, 14.33. HRMS (ESI) 





EDOT-Ala. Compound 4 (1.00 g, 2.37 mmol) was dissolved in THF (10 mL), and 500 
mM HCl in water (10 mL) was added to the solution. After stirring at room temperature 
for 1 h, lithium hydroxide (1.00 g, 41.7 mmol) was added, and the reaction mixture was 
stirred at room temperature for 16 h. The product was purified by C18-reversed phase 
chromatography (water:methanol 100:0 to 70:30), yielding 370 mg (68%) of a white 
solid. 1H NMR (500 MHz, MeOD) δ 6.54–6.46 (m, 2H), 4.46–4.30 (m, 1H), 4.31–4.19 
(m, 1H), 3.99 (m, 1H), 3.63 – 3.50 (m, 1H), 2.14 – 1.76 (m, 2H); 13C NMR (126 MHz, 
MeOD) δ 180.74, 143.13, 143.08, 100.37, 100.36, 100.06, 72.66, 69.62, 53.80, 36.36. 
HRMS (ESI) calculated for C9H11NO4S [M+H]+: m/z = 230.0487; found: 230.0468. 
 
2.5.3. Cloning 
General. The plasmids were constructed by standard recombinant DNA technology using 
E. coli DH10B strain. DNA oligomers for PCRs were purchased from IDT (Coralville, IA). 
Bacteria were grown on LB/agar plates and LB liquid media with the following antibiotic 
concentrations unless indicated otherwise: 100 μg/mL ampicillin, 100 μg/mL carbenicillin, 
50 μg/mL kanamycin, 100 μg/mL spectinomycin, and 40 μg/mL chloramphenicol. The 
plasmid pQE80-SYNZIP3 was a kind gift from Dr. Bradley R. Silverman. The plasmid 
pEVOL-MmPylRS(N346A/C348A)-PylT50 was a kind gift from Prof. Wenshe R. Liu. The 
plasmids for cell viability-based selections34,35 were kind gifts from Prof. Peter G. Schultz. 
SP and plasmids required for phage-assisted evolution36 were kind gifts from Prof. David 
R. Liu. Plasmids and their corresponding coding sequences are presented in 2.7. DNA and 
Protein Sequences. 
pQE80-SYNZIP3-S4W. The pQE80-SYNZIP3 plasmid confers resistance to ampicillin 
and carries N- and C-terminal 6xHis-Tags and SYNZIP3 under the T5 promoter. A Trp 
codon was inserted by site-directed mutagenesis of Ser at position 4, yielding the plasmid 
pQE80-SYNZIP-S4W. 
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pQE80-GFP-S4am. The previously reported plasmid pQE-GFPrmAM62 was subjected 
to site-directed mutagenesis to introduce two mutations: S4am and am251oc (am: amber, 
oc: ochre), yielding the plasmid pQE80-GFP-4am. 
Construction of the pBK-MmPylRS(Y306A/Y384F) library. The 
MmPylRS(N346A/C348A) gene was amplified from pEVOL-MmPylRS(N346A/C348A)-
PylT and cloned into the pBK vector, replacing the gene of an aaRS variant to yield the 
plasmid pBK-MmPylRS(Y306A/Y384F). To construct the site-saturation mutagenesis 
library, NNK (N = A, T, G, C, K = G, T) mutations were introduced at five sites (L305, 
Y306, L309, Y384, W417) by overlap extension PCR following the previous study.55 The 
primers used to introduce NNK mutations are presented in 2.8. Primers and Plasmids. The 
gene library was digested with the restriction enzymes NdeI and NsiI, purified on 1% 
agarose gel, and ligated into the pBK vector that was digested by NdeI and PstI, yielding 
the pBK-MmPylRS(Y306A/Y384F) library. The ligation products were electroporated into 
E. coli Top10 cells, and the cells were rescued in SOC medium for 1 hour at 37 ºC, grown 
in 50 mL of 2xYT at 37 ºC to an optical density at 600 nm (OD600) of 1.0. To evaluate the 
transformation efficiency, the rescued SOC culture was serially diluted and plated on LB 
agar plate with kanamycin. The calculated library size was 1.0×106 independent 
transformants. Ten colonies were picked from the plate to confirm mutations. No 
significant mutation bias was observed at the targeted sites. 
2.5.4. Protein Expression and Purification 
Incorporation of EDOT-Ala into SYNZIP3 by E. coli TrpRS. 
To incorporate EDOT-Ala into SYNZIP3, a Trp auxotrophic strain of E. coli (KY35) 
derived from DH10B was transformed with pQE-SYNZIP3-S4W. E. coli cultures were 
grown in M9 minimal media (5 mL) supplemented with 0.4% glycerol, 25 mg/L thiamine, 
1 mM MgSO4, 0.1 mM CaCl2, 20 amino acids (40 mg/L, respectively), and 100 mg/L 
ampicillin at 37 °C to an OD600 of 0.5-0.7. Then the cells were sedimented by 
centrifugation, washed twice with 0.9% NaCl, and resuspended in M9 minimal media (5 
mL) supplemented with 0.4% glycerol, 25 mg/L thiamine, 1 mM MgSO4, 0.1 mM CaCl2, 
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19 amino acids without Trp (40 mg/L, respectively), 100 mg/L ampicillin, and 3 mM 
EDOT-Ala. Protein expression was induced by addition of 1 mM isopropyl-β-
thiogalactopyranoside (IPTG) for 5 hours, and the cells were then harvested by 
centrifugation. 
Incorporation of EDOT-Ala into DHFR by yPheRS(T415G). 
A Phe/Trp double auxotrophic strain of E. coli harboring the plasmids coding the 
yPheRS(T415G)/ytRNAPheCUA_UG pair and mDHFR with an amber codon at position 38 
was used for the expression.43 E. coli cultures were grown in M9 minimal media (5 mL) 
supplemented with 0.4% glycerol, 25 mg/L thiamine, 1 mM MgSO4, 0.1 mM CaCl2, 20 
amino acids (40 mg/L, respectively), and antibiotics (100 mg/L ampicillin and 50 mg/L 
kanamycin) at 37 °C to an OD600 of 0.5-0.7. Then the cells were sedimented by 
centrifugation, washed twice with 0.9% NaCl, and resuspended in M9 minimal media (5 
mL) supplemented with 0.4% glycerol, 25 mg/L thiamine, 1 mM MgSO4, 0.1 mM CaCl2, 
18 amino acids (40 mg/L, respectively), 0.01 mM Trp, 0.03 mM Phe, antibiotics (100 mg/L 
ampicillin and 50 mg/L kanamycin) and 3 mM EDOT-Ala. Protein expression was induced 
by addition of 1 mM IPTG for 5 hours, and the cells were harvested by centrifugation. 
Incorporation of EDOT-Ala into GFP by MmPylRS(N346A/C348A). 
To incorporate EDOT-Ala into GFP, BL21(DE3) or KY35 strain of E. coli was 
transformed with pQE-GFP-S4am. For expression in the BL21(DE3) strain, E. coli cultures 
were grown in 2xYT media at 37 °C to an OD600 of 0.5-0.7. Then 2 mM EDOT-Ala was 
added, and protein expression was induced by addition of 1 mM IPTG for 16 hours. 
For expression in the KY35 strain, E. coli cultures were grown in M9 minimal media (5 
mL) supplemented with 0.4% glycerol, 25 mg/L thiamine, 1 mM MgSO4, 0.1 mM CaCl2, 
20 amino acids (40 mg/L), and ampicillin (100 mg/L) at 37 °C to an OD600 of 0.5-0.7. 
Then the cells were sedimented by centrifugation, washed twice with 0.9% NaCl, and 
resuspended in M9 minimal media (5 mL) supplemented with 0.4% glycerol, 25 mg/L 
thiamine, 1 mM MgSO4, 0.1 mM CaCl2, 17 amino acids without Phe, Tyr and Trp (40 
 37 
mg/L, respectively), 100 mg/L ampicillin, and 2 mM EDOT-Ala. Protein expression was 
induced by addition of 1 mM IPTG for 5 h. 
Protein Purification. After expression, cells were harvested by centrifugation, 
resuspended in lysis buffer (0.1 M Na2HPO4, 10 mM imidazole; pH 8.0), and lysed by 
sonication. Lysates were cleared by centrifugation and incubated with Ni-NTA agarose. 
The resin was washed with lysis buffer and wash buffer (0.1 M Na2HPO4, 25 mM 
imidazole; pH 8.0). Protein was eluted with elution buffer (0.1 M Na2HPO4, 250 mM 
imidazole; pH 8.0), dialyzed against water, and lyophilized for storage. 
SDS-PAGE. After protein expression, cells were lysed by resuspension in a lysis buffer 
(100 mM Tris·HCl, pH 8.0, 1% SDS). Lysates were mixed with an SDS loading buffer 
(0.05% bromophenol blue, 0.1 M dithiothreitol (DTT), 10% glycerol, 2% SDS, 50 mM 
Tris·HCl; pH 8.0), heated to 95 °C for 5 min, and separated via SDS-PAGE. The gel was 
stained with Colloidal Blue (Life Technologies) and imaged on a Typhoon gel imager (GE 
Healthcare). 
Flow Cytometry. After expression of GFP, cells were harvested by centrifugation, washed 
twice with PBS and strained through a 40 µm filter to remove aggregates. Flow cytometry 
was performed on a MoFlo XDP cell sorter equipped with an argon ion laser emitting at 
488 nm. Data was analyzed in MATLAB using a custom software EasyFlow.63 
2.5.5. Cell Viability-Based Selection 
The selection followed the reported procedure.34,35 The positive selection plasmid pRep-
PylT-GFP confers tetracycline resistance and encodes CAT with an amber codon at 
position 112, T7 RNA with amber codons at position 6 and 114, GFP under the T7 
promoter, and the amber suppressor tRNAPyl under the constitutive lpp promoter. The 
negative selection plasmid pNeg-PylT conferes ampicillin resistance and encodes a 
bacterial toxin barnase with amber codons at positions 2 and 44 and the amber suppressor 
tRNAPyl under the constitutive lpp promoter. 
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For the positive selection, the pBK-MmPylRS(Y306A/Y384F) library was transformed 
into E. coli TOP10 electrocompetent cells (Invitrogen) with the pRep plasmid. Cells were 
grown on LB agar plates supplemented with 12 μg/mL tetracycline, 50 μg/mL kanamycin, 
68 μg/mL chloramphenicol, and 2 mM EDOT-Ala. After 72 hours of incubation at 37 ºC, 
colonies were collected and grown in LB media (10 mL) supplemented with 12 μg/mL 
tetracycline and 25 μg/mL kanamycin. The plasmids were extracted and purified with 
Zyppy Plasmid Miniprep Kit (Zymo Research). 
For the negative selection, the pBK-MmPylRS(Y306A/Y384F) library collected from the 
positive selection was transformed into E. coli TOP10 electrocompetent cells (Invitrogen) 
with the pNeg plasmid. Cells were grown on LB agar plates supplemented with 50 μg/mL 
kanamycin, 200 μg/mL ampicillin, and 0.2% arabinose. After 18 hours of incubation at 37 
ºC, the colonies were collected to extract plasmids. The plasmids were used for another 
cycle of positive selection. 
2.5.6. Phage-Assisted Evolution 
We performed phage-assisted evolution via the non-continuous method.36 The plasmids 
used for the experiment are listed in 2.8. Primers and Plasmids. S1030 cells harboring the 
required accessory plasmid and complementary plasmid were transformed with a 
mutagenesis plasmid. The cells were rescued in SOC media with 0.4% glucose for 1 hour 
at 37 ºC and grown on LB agar plates supplemented with 0.4% glucose and antibiotics. 
Single colonies of the transformed cells were picked and grown in LB media supplemented 
with 0.4% glucose and antibiotics for 14 hours at 37 ºC. The LB cultures were diluted 50-
fold into 2xYT media (5 mL) supplemented with 0.4% glucose and antibiotics and grown 
to an OD600 of 0.5-0.7. Then cells were harvested by centrifugation and resuspended in 
2xYT media (5 mL) supplemented with 5 mM arabinose and 2 mM EDOT-Ala. The 
cultures were inoculated with SP solution (0.2 pfu) and incubated for 12 hours at 37 ºC. 
The cells were centrifuged, and the supernatant was filtered with 0.22 µm syringe filter. 
The obtained SP solutions were stored at 4 ºC and used for the next cycle of evolution. 
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Negative selection was performed in the same procedure without addition of EDOT-Ala 
in the media. 
For positive selection in minimal media, the overnight LB cultures of the host cell were 
diluted 50-fold into M9 minimal media (5 mL) supplemented with 0.4% glucose, 25 mg/L 
thiamine, 1 mM MgSO4, 0.1 mM CaCl2, 20 canonical amino acids (40 mg/L, respectively), 
and antibiotics, and grown to an OD600 of 0.5-0.7. Then cells were harvested by 
centrifugation and resuspended in M9 minimal media (5 mL) supplemented with 5 mM 
arabinose, 25 mg/L thiamine, 1 mM MgSO4, 0.1 mM CaCl2, 17 canonical amino acids 
without Tyr, Phe, Trp (40 mg/L, respectively), 2 mM EDOT-Ala, and antibiotics. The 
cultures were inoculated with SP solution (0.2 pfu) and incubated for 12 hours at 37 ºC. 
The cells were centrifuged, and the supernatant was filtered with 0.22 µm syringe filter. 
The obtained SP solutions were stored at 4 ºC and used for the next cycle of evolution.	 
Plaque Assay. S1059 cells were grown in 2xYT media supplemented with antibiotics to an 
OD600 of 0.6–0.8. The SP solution was serially diluted at 10-fold, yielding six total 
samples. Each solution (2 µL) was added to 100 µL of the cell culture, and 900 µL of top 
agar (0.7% bacteriological agar in 2xYT) dissolved at 55 ºC was mixed with the infected 
cells. The mixtures were plated on 2xYT agar plates without antibiotics. After incubation 
for 12 hours at 37 ºC, the number of plaques in each sample was counted and the phage 








2.6. NMR Spectra 
 
Figure S2.1. 1H NMR spectrum (500 MHz) of EDOT-Ala in MeOD at 22 ºC. 
 
Figure S2.2. 13C NMR spectrum (126 MHz) of EDOT-Ala in MeOD at 22 ºC. 
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*The single codon for Trp is highlighted in red. N- and C-terminal 6xHis-Tags are 

















*The amber codon is highlighted in red.  N-terminal 10xHis-Tag is highlighted in blue. 
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2.8. Primers and Plasmids  









*N represents A, T, G, C, and M represents C, A. 
 
Table 2.2. Plasmids used for phage-assisted evolution.36 
Selectio
n/string
ency Type Name 
Anti 
biotic ORF 1   ORF 2   ORF 3   
        Prom Gene Prom Gene Prom Gene 
Positive
-low 
AP pDB007+ Carb P(T7) gIII, luxAB P(proK) tyrT     
CP pDB023f1 Spec P(psp) 
T7RNAP(S12∗,
S203∗)         
MP MP4 Cm P(psp) 
dnaQ926, dam, 
seqA P(C) araC     
Positive
-high AP pDB026a,e,f Carb P(psp) 
gIII(P29∗,P83∗,
Y184∗), luxAB P(proK) tyrT     
MP MP4 Cm P(psp) 
dnaQ926, dam, 
seqA P(C) araC     
Negativ
e 




CP pDB016 Spec P(T7) gIII-neg         
MP MP4 Cm P(psp) 
dnaQ926, dam, 
seqA P(C) araC     
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C h a p t e r  3  
INCORPORATION OF EDOT-LYS INTO PROTEINS 
3.1. Abstract 
Genetic incorporation of ncAA with EDOT functionality will extend the potential 
of protein-based materials for their applications in bioelectronics. Because our 
attempts to incorporate EDOT-Ala into cellular proteins were unsuccessful, we 
synthesized another ncAA, which was termed EDOT-Lys. When a mutant 
MmPylRS was co-expressed with the reporter protein GFP, E. coli cells showed 
strong fluorescence as an indication of successful incorporation of EDOT-Lys. The 
incorporation was fully confirmed by fluorescence measurements, SDS-PAGE, and 
MALDI-TOF mass spectrometry. The technique developed here will open up the 













Genetic incorporation of non-canonical amino acids (ncAAs) provides a powerful 
tool to introduce desirable functionalities into proteins. One novel application of 
this technique is to incorporate an electroactive functional group into proteins, 
which can be subsequently polymerized into conductive polymers. To this end, we 
sought to genetically incorporate an ncAA bearing 3,4-ethylenedioxythiophene 
(EDOT) functionality by harnessing the E. coli protein biosynthesis machinery. In 
the previous chapter, we synthesized an amino acid EDOT-Ala as an analogue of 
aromatic canonical amino acids. However, incorporation of EDOT-Ala was 
unsuccessful despite our effort to evolve cognate aminoacyl t-RNA synthetases 
(aaRSs) (see Chapter 2). 
In addition to the derivatives of phenylalanine (Phe), analogues of pyrrolysine (Pyl) 
have also been used to introduce bulky functional groups into proteins.1,2 Pyl is the 
22nd canonical amino acid (the 21st being selenocysteine) that is found in the 
genetic code of some methanogenic archaea.1 Pyl is co-translationally inserted in 
response to the amber stop codon. Due to the orthogonality in E. coli and 
eukaryotes, the PylRS/tRNACUA pairs have been widely used to incorporate ncAAs. 
Pyl carries a 4-methylpyrroline unit linked to the side chain amine group of lysine 
via an amide bond. Therefore, the pyrrolysyl tRNA synthetase (PylRS) has a large 
binding pocket to accommodate the methylpyrroline group. Mutagenesis of PylRS 
has further extended the binding pocket to accommodate Pyl analogues with bulky 
functional groups. Examples include Pyl analogues with carboxybenzyl (Cbz),3 
cyclooctyne,4  bicyclononyne (BCN),5 norbornene,6 furan,7 and coumarin groups.8 
Many of these ncAAs have been incorporated by an engineered PylRS from 
Methanosarcina mazei (MmPylRS(Y306A/Y384F)) developed by Yokoyama and 
coworkers.3 Therefore, we envisioned that designing an ncAA with EDOT group as 
a Pyl analogue would be an effective approach to incorporate EDOT functionality 
into proteins.  
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3.3. Results and Discussion 
3.3.1. Synthesis of EDOT-Lys 
We designed and synthesized a Pyl analogue bearing an EDOT group, which we 
termed EDOT-Lys (Figure 3.1). Because Pyl analogues with bulky functional 
groups have been successfully incorporated by variants of MmPylRS and 
MbPylRS,1,2 we expected that EDOT-Lys could be incorporated by reported PylRS 
variants or by evolved variants of them. 
 
Figure 3.1. Chemical structures of EDOT-Lys, Pyl, and previously reported Pyl 
analogues.3,5,7,8 
The synthetic scheme of EDOT-Lys is shown in Figure 3.2. For the synthesis of 
EDOT-Lys, we activated hydroxymethyl EDOT (5) with N,N’-disuccinimidyl 
carbonate (DSC) to obtain EDOT-NHS (6), which was treated with Fmoc-protected 
lysine. Deprotection of the Fmoc group with piperidine yielded EDOT-Lys. All the 
reactions proceeded under mild conditions with high yields (overall 53%), and 
EDOT-Lys was readily synthesized on gram scales. The details of the amino acid 
synthesis and NMR data are provided in Sections 3.4.2 and 3.6. 
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Figure 3.2. Synthesis of EDOT-Lys.  
3.3.2. Incorporation of EDOT Functionality into GFP 
To incorporate EDOT-Lys into recombinant proteins, we employed the MmPylRS 
with two mutations at the active site (Y306A/Y384F), which was developed by 
Yokoyama and coworkers.2,3 We chose the green fluorescent protein (GFP) as a test 
protein for investigation of the capacity of the MmPylRS(Y306A/Y384F)/tRNAPyl 
pair to incorporate EDOT-Lys into recombinant proteins in E. coli. GFP was 
expressed from the plasmid pET16b-GFP-25am under the control of bacteriophage 
T7 promoter (Novagen). An amber codon was placed at position 25, which is 
upstream the GFP gene (Figure 3.3a), which allowed evaluation of the 
incorporation based on the measurement of whole-cell fluorescence. The 
MmPylRS(Y306A/Y384F)/tRNAPyl pair was expressed from the modified pUltra 
plasmid.9 The MmPylRS(Y306A/Y384F) gene was placed under the IPTG-
inducible tacI promoter and the tRNAPyl was placed under the constitutive proK 
promoter. We co-transformed E. coli BL21(DE3) with the plasmids for the 
expression of GFP and the MmPylRS(Y306A/Y384F)/tRNAPyl pair, and expressed 
the proteins in the absence and presence of 1 mM EDOT-Lys. 
Cellular fluorescence as well as SDS-PAGE analysis of the lysate revealed the 
expression of GFP-25am in the presence of EDOT-Lys, whereas no expression was 
observed in the absence of EDOT-Lys (Figure 3.3b, c). In addition, we expressed 
GFP-25am in a large scale and purified by Ni-NTA chromatography (typical yield: 
20 mg/L). The purified protein was digested by trypsin and analyzed by MALDI-
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TOF and tandem mass spectrometry (Figure 3.4). The mass spectra of trypsin-
digested GFP-25am showed the peaks corresponding to the peptides carrying 
EDOT-Lys. No peak was observed for the off-target incorporation of canonical 
amino acids. These results indicate the successful incorporation of EDOT-Lys. 
 
Figure 3.3. Incorporation of EDOT-Lys into GFP. (a) Sequence of GFP with amber codon. 
(b) Fluorescence intensity of E. coli measured at 510 nm (n = 4) and (c) Coomassie-stained 
SDS-PAGE. M: marker, (i) uninduced, (ii) no ncAA, (iii) EDOT-Lys. 
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Figure 3.4. (a) MALDI mass spectra for trypsin-digested GFP-25am. The expected mass 
peak for the peptide with EDOT-Lys (GSVDXGSLSK; X = EDOT-Lys) was observed; 
calculated for C48H79N12O20S [M+H]+: m/z = 1175.525; found: 1175.543. (b) Tandem 
mass spectrum of the parent peak for GSVDXGSLSK. α-cyano-4-hydroxycinnamic acid 
(CHCA) was used as a matrix. 
 
3.4. Conclusion 
We prepared an amino acid EDOT-Lys as a Pyl analogue and successfully 
incorporated it into a GFP reporter using an MmPylRS mutant. Incorporation was 
confirmed by expression of GFP as well as the analysis of the expressed protein by 
MALDI-TOF mass spectrometry. We believe that developing a technique to 
incorporate EDOT functionality into proteins is an important step towards 
fabrication of protein-based conductive materials.  
3.5. Experimental Procedures 
3.5.1. General 
All the reagents for organic synthesis were purchased from Sigma Aldrich and 
Tokyo Chemical Industry Co., Ltd. (TCI), and used as received without further 
purification. For column chromatography, Biotage Isolera Spektra equipped with a 
SNAP HP-Sil 10 g cartridge or a SNAP ULTRA C18 12 g cartridge was used. 1H 
(500 MHz) and 13C NMR (126 MHz) spectra were recorded on a Varian Inova 500 
spectrometer. Analytical HPLC analyses for small compounds were performed with 
an Agilent 1290 Infinity Series HPLC instrument at the Center for Catalysis and 
Chemical Synthesis in the Caltech Beckman Institute.	 High-resolution mass 
spectrometry (HRMS) was performed with an LCT Premier XE Electrospray TOF 
Mass Spectrometer with electrospray ionization (ESI) at the Caltech CCE Multiuser 
Mass Spectrometry Laboratory. Matrix-assisted laser desorption/ionization time-of-
flight mass (MALDI-TOF MS) spectrometry measurements were carried out on a 
Bruker Daltonics autoflexTM speed MALDI-TOF/TOF spectrometer at the Caltech 
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CCE Multiuser Mass Spectrometry Laboratory. A Tecan Safire II plate reader was 
used for the fluorescence measurement in 96-well plates.  
3.5.2. Synthesis and Characterization of Compounds 
 
EDOT-NHS (6). Hydroxymethyl EDOT (5) (800 mg, 4.65 mmol) and 4-
dimethylaminopyridine (85 mg, 0.70 mmol) were dissolved in anhydrous DCM (2 
mL) under Ar atmosphere. N,N’-disuccinimidyl carbonate  (2.10 g, 4.92 mmol) 
was added, and the reaction mixture was stirred at room temperature for 18 h. A 
solution of 5% citric acid (40 mL) was added and the reaction was extracted with 
DCM (3 x 20 mL). The combined organic layers were washed with saturated 
NaHCO3 (2x 70 mL) and brine (2x100 mL), dried over MgSO4, and concentrated 
in vacuo, yielding 1.4 g (95%) of a white solid. 1H NMR (500 MHz, CDCl3) δ 
6.40 (d, J = 3.6 Hz, 1H), 6.37 (d, J = 3.7 Hz, 1H), 4.58-4.46 (m, 3H), 4.29-4.24 
(m, 2H), 2.85 (s, 4H); 13C NMR (126 MHz, CDCl3) δ 168.47, 151.62, 141.02, 
140.48, 100.72, 100.50, 70.71, 68.33, 65.06, 25.60. HRMS (ESI) calculated for 
C12H11NO7S [M+H]+: m/z = 314.0329; found: 314.0314. 
 
 
Fmoc-EDOT-Lys (7). Nα-Fmoc-L-lysine hydrochloride (646 mg, 1.60 mmol) 
and sodium bicarbonate (268 mg, 3.19 mmol) were dissolved in dioxane:H2O (4:1, 
10 mL). To the solution was added EDOT-NHS (6) (500 mg, 1.60 mmol) and the 
resulting mixture was allowed to stir at room temperature for 16 h. After 
completion of the reaction, 5% citric acid (80 mL) was added and the reaction 
was extracted with DCM (3 x 20 mL). The combined organic layers were dried 
over MgSO4 and concentrated in vacuo to afford Fmoc-EDOT-Lys (7) as yellow 






EDOT-Lys. Fmoc-EDOT-Lys (7) (800 mg, 1.41 mmol) was dissolved in 20% 
piperidine in DCM (15 mL) and allowed to stir at room temperature for 18 h. After 
the reaction, the solution was preciptated in diethyl ether (60 mL) and washed with 
diethyl ether (x3) and ice-cold MeOH to afford 365 mg of a white solid (75%). 1H 
NMR (500 MHz, D2O) δ 6.41 (s, 1H), 6.41 (s, 1H), 4.42 – 3.95 (m, 4H), 3.72 – 
3.42 (m, 2H), 3.08 (q, J = 5.9 Hz, 2H), 1.91 – 1.21 (m, 6H); 13C NMR (126 MHz, 
HFIP-d2) δ 175.90, 160.62, 142.19, 142.18, 102.69, 102.68, 74.34, 67.69, 65.21, 
58.49, 41.95, 31.94, 30.73, 23.76. HRMS (ESI) calculated for C14H20N2O6S 
[M+H]+: m/z = 345.1115; found: 345.1121. 
3.5.3. Cloning 
General. The plasmids were constructed by standard recombinant DNA technology 
using an E. coli DH10B strain. DNA oligomers for PCRs were purchased from IDT 
(Coralville, IA). Bacteria were grown on LB/agar plates and LB liquid media with 
the following antibiotic concentrations: 100 μg/mL spectinomycin and 100 μg/mL 
ampicillin. The pUltra vector9 was the kind gift from Prof. Peter G. Schultz. The 
plasmid encoding MmPylRS(N346A/C348A)10 was a kind gift from Prof. Wenshe 
R. Liu. Plasmids and their corresponding coding sequences are presented in 3.7. 
DNA and Protein Sequences. 
pUltra-MmPylRS(Y306A/Y384F). The pUltra vector confers resistance to 
spectinomycin and encodes aaRS under an IPTG-inducible tacI promoter and 
tRNACUA under a constitutive proK promoter. The aaRS was replaced with 
MmPylRS(N346A/C348A) gene, yielding the plasmid pUltra- 
MmPylRS(N346A/C348A). A series of mutations (Y306A, A346N, A348C, and 
Y384F) were introduced by site-directed mutagenesis, yielding the plasmid pUltra-
MmPylRS(Y306A/Y384F). 
pET16b-GFP-25am. The pET16b vector (Novagen) confers resistance to 
ampicillin and carries an N-terminal 10xHis-Tag and cloning sites under the T7 
promoter. The GFP gene was amplified from a previously reported plasmid pQE-
GFPrmAM,11 and inserted to a cloning site by Gibson Assembly. An amber stop 
codon was introduced at the position 25. 
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3.5.4. Protein Expression and Purification 
To incorporate EDOT-Lys into GFP, an E. coli strain BL21(DE3) was co-
transformed with pUltra-MmPylRS(Y306A/Y384F) and pET16b-GFP-25am. E. 
coli cultures were grown in 2xYT media at 37 °C to an optical density at 600 nm 
(OD600) of 0.5-0.7. Then 1 mM EDOT-Lys was added, and protein expression was 
induced by addition of 1 mM isopropyl-β-thiogalactopyranoside (IPTG). After 15 h, 
we diluted the cells with phosphate buffered saline (PBS), and analyzed the whole-
cell fluorescence by plate reader. For SDS-PAGE, cells were lysed by resuspension 
in a lysis buffer (100 mM Tris·HCl, pH 8.0, 1% SDS). Lysates were mixed with an 
SDS loading buffer (0.05% bromophenol blue, 0.1 M dithiothreitol (DTT), 10% 
glycerol, 2% SDS, 50 mM Tris·HCl; pH 8.0), heated to 95 °C for 5 min, and 
separated via SDS-PAGE. The gel was stained with Colloidal Blue (Life 
Technologies) and imaged on a Typhoon gel imager (GE Healthcare). 
For mass spectrometry, the cells were harvested by centrifugation after expression, 
resuspended in lysis buffer (0.1 M Na2HPO4, 10 mM imidazole; pH 8.0), and lysed 
by sonication. Lysates were cleared by centrifugation, and incubated with Ni-NTA 
agarose. The resin was washed with a lysis buffer and a wash buffer (0.1 M 
Na2HPO4, 25 mM imidazole; pH 8.0). Protein was eluted with an elution buffer 
(0.1 M Na2HPO4, 250 mM imidazole; pH 8.0), dialyzed against water, and 
lyophilized for storage. 
3.5.5. MALDI-TOF Mass Spectrometry 
The dry protein powder was dissolved in 100 mM NH4HCO3 (pH 8.0) to a final 
concentration of 1 mg/mL. Trypsin (Sigma-Aldrich; 10 U/mL) was added, and the 
solution was incubated at 37°C for 3 h. Proteolysis was quenched by addition of a 
final concentration of 0.1% trifluoroacetic acid (TFA) and the peptides were 
purified by C18 ZipTip (Millipore) according to the manufacturer’s protocol. The 
peptides were eluted in 50% acetonitrile with 0.1% TFA and analyzed by MALDI-
TOF mass spectrometry.  
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3.6. NMR Spectra 
 
Figure S3.1. 1H NMR spectrum (500 MHz) of EDOT-Lys in D2O at 22 ºC. 
 
 
Figure S3.2. 13C NMR spectrum (126 MHz) of EDOT-Lys in HFIP-d2 at 22 ºC. 
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*The amber codon is highlighted in red.  N-terminal 10xHis-Tag is highlighted in 
blue. 
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C h a p t e r  4  
ELECTROPOLYMERIZATION OF XTEN WITH AN EDOT 
GROUP 
 4.1. Abstract 
Genetic incorporation of EDOT-Lys could be a useful approach to create protein-
based conductive materials. To demonstrate the utility of EDOT-Lys for 
electrochemical synthesis of protein–PEDOT conjugates, we incorporated EDOT-
Lys into a model protein XTEN and performed electropolymerization by cyclic 
voltammetry. When electropolymerized with a water-soluble, self-doping EDOT 
monomer (EDOT-S), XTEN carrying EDOT-Lys (XTEN-E49am) formed a blue 
precipitate in the solution, whereas XTEN carrying no EDOT-Lys (XTEN-noam) 
did not form any precipitate after electropolymerization. Notably, MALDI-TOF 
mass spectra with an internal standard protein revealed that the large amount of 
XTEN-E49am was removed from the solution upon electropolymerization, 
suggesting that XTEN-E49am was integrated into the solid fraction of the product. 
Further analysis by FT-IR spectroscopy revealed that the solid product contains 
both XTEN-E49am and PEDOT-S. In addition, we investigated the effect of the 
chemical environment surrounding EDOT-Lys using a series of model peptides. 
Electropolymerization did not proceed in the applied potential range when Cys, 
Lys, Met, and Trp were located adjacent to EDOT-Lys. The peptide carrying Arg 
next to EDOT-Lys revealed a higher oxidation potential compared to the peptides. 
Nonetheless, electropolymerization of XTEN-E49am carrying these adjacent amino 
acids (XTEN-E49am-G50Z; Z = Cys, Lys, Met, Arg, Trp) with EDOT-S proceeded 
well without noticeable effects from the adjacent amino acids. The technique 
presented here provides a versatile strategy for the synthesis of protein–PEDOT 
conjugates and opens new avenues for protein-based conductive materials that are 
useful for various bioelectronics applications. 
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4.2. Introduction 
The genetic code expansion technique has been revolutionizing the approach to 
develop protein-based materials.1,2 One novel application of this technique is 
creating a protein-based conductive polymer using an electroactive non-canonical 
amino acid (ncAA). To explore this possibility, we incorporated an amino acid 
bearing 3,4-ethylenedioxythiophene (EDOT) group (designated EDOT-Lys) into 
proteins (see Chapter 3). In this chapter, we describe the polymerization of proteins 
through the pendant EDOT-Lys residue via electropolymerization. 
PEDOT is often synthesized via one of the two major approaches: oxidative 
chemical polymerization and electropolymerization.3,4 Electropolymerization has 
advantages over oxidative chemical polymerization in that it only requires short 
reaction time and a small volume of the sample, while chemical polymerization is 
preferred for large scale synthesis.3,4 Figure 4.1 describes the proposed mechanism 
of polymerization of the EDOT monomer.5,6 Upon application of an oxidation 
potential or addition of an oxidant, EDOT monomers form radical cations. Two 
radical cations couple together to form a dimer of EDOT, and the repeat of this 
process elongates the polymer chain to form PEDOT. The oxidation of a neutral 
oligomer to the radical cation proceeds much faster than that of the EDOT 
monomer, and therefore, the initial monomer oxidation is the rate-limiting step.5 
 
Figure 4.1. Mechanism of polymerization of the EDOT monomer. 
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In electropolymerization, an oxidation potential or current is applied to a monomer 
solution through the working electrode connected to an electrochemical instrument. 
The type of electrolytes, solvents, and reaction time affect the property of the 
polymer product.7,8 Although the EDOT monomer is not soluble in water, previous 
studies have shown that electropolymerization of EDOT proceeds in aqueous 
solutions.9–11 Electropolymerization of EDOT in the presence of protein has also 
been demonstrated.12–14 Functionalized EDOT monomers such as EDOT with 
sulfonate group (EDOT-S) are also used to synthesize water-soluble PEDOT,15,16 
which is useful for biological applications.17–21 
4.3. Results and Discussion 
4.3.1. Electropolymerization of XTEN with an EDOT Group 
To evaluate the utility of EDOT-Lys for polymerization, we employed an 
unstructured protein XTEN as a model protein. XTEN is a soluble, unstructured, 
artificial protein developed to prolong the in vivo retention of therapeutic 
proteins.22–24 Conjugation with XTEN (XTENylation) increases the hydrodynamic 
diameter of target molecules in a similar manner as poly(ethylene glycol).22–24 
XTEN is composed of six hydrophilic amino acids (Ala, Glu, Gly, Pro, Ser, and 
Thr).22 We introduced a C-terminal 6xHis-Tag to an XTEN construct and mutated a 
Glu residue at position 49 to an amber codon (XTEN-E49am; ~10 kDa). The 
protein was expressed in E. coli BL21(DE3) harboring pUltra-
MmPylRS(Y306A/Y384F) in the presence of EDOT-Lys. A control protein with no 
amber codon (XTEN-noam) was also prepared. 
Electropolymerization was performed in aqueous solutions of the proteins (0.8 
mM) with a supporting electrolyte NaClO4 (100 mM), a self-doped EDOT 
derivative EDOT-S (25 mM),15,16 and 5% trifluoroacetic acid (TFA). The solutions 
were dropped on the fluorine-doped tin oxide (FTO) working electrode. The 
potential was applied by cyclic voltammetry (CV) (Elow = +0.65 V; Ehigh = +1.5 V; 
scan rate = 100 mV/s; 5 cycles) in a three-electrode cell equipped with an Ag/AgCl 
 68 
as the reference electrode and a Pt wire as the counter electrode. We observed the 
onset of oxidation current at 1.1 V in all three samples containing (i) EDOT-S, (ii) 
EDOT-S and XTEN-noam, and (iii) EDOT-S and XTEN-E49am (Figure 4.2). The 
solutions turned a characteristic blue color as an indication of the formation of 
PEDOT chains. The consumption of EDOT-S monomer was calculated as 97% by 
NMR spectra of EDOT-S before and after electropolymerization (Figure S4.1). The 
current decreased over the CV cycles, which is attributed to the deposition of the 
polymer on the FTO electrodes. MALDI mass spectrometry of the 
electropolymerized XTEN-E49am revealed the appearance of new peaks 
corresponding to the addition of EDOT-S monomer units to the protein, whereas 
only the original protein peak was observed for XTEN-noam (Figure 4.3, Figure 
S4.2). Notably, the solution of (iii) EDOT-S and XTEN-E49am formed a 
precipitate immediately after electropolymerization (Figure 4.3e), and large 
aggregates (over the size of 100 µm) were observed under the optical microscope 
(Figure 4.4c, f). No aggregates or only small aggregates were formed after 
electropolymerization in the solutions containing (i) EDOT-S and (ii) EDOT-S and 
XTEN-noam (Figure 4.4a, b, d, e). 
 
Figure 4.2. Electropolymerization of (a) EDOT-S, (b) EDOT-S and XTEN-noam, and (c) 
EDOT-S and XTEN-E49am by cyclic voltammetry on FTO electrodes (Elow = +0.65 
V; Ehigh = +1.5 V; scan rate = 100 mV/s; 5 cycles). Samples are prepared at [XTEN] = 0.8 




Figure 4.3. MALDI-TOF mass spectra of (a) XTEN-noam and (b) XTEN-E49am after 
electropolymerization with EDOT-S. Samples were collected by dissolving the deposited 
films on the FTO electrodes into water. Arrows indicate the peak positions corresponding 
to the addition of EDOT-S to the protein (XTEN-E49am–nEDOT-S; n = 0-5), and * 
indicates the proteins without Met cleavage. (c, d, e) Sample solutions after 
electropolymerization in 0.2 mL PCR tubes. (c) EDOT-S, (d) EDOT-S with XTEN-noam, 
and (e) EDOT-S with XTEN-E49am. 
 
Figure 4.4. Optical microscope images of sample solutions after electropolymerization. (a, 
e) EDOT-S, (b, f) EDOT-S with XTEN-noam, and (c) EDOT-S with XTEN-E49am. Scale 
bar: (a-c) 100 µm, (d-f) 25 µm. Solutions were cast between two glass cover slips with a 
120 µm spacer. 
To further confirm that the aggregation is formed specifically from the protein with 
the pendant EDOT group, we prepared an internal standard protein for the analysis 
by mass spectrometry. The standard protein was prepared by deleting six residues 
in XTEN-noam (designated as sXTEN-noam). sXTEN-noam has a smaller 
molecular weight than XTEN-noam and its mass peak is well-separated from the 
one of XTEN-E49am. Therefore, sXTEN-noam can be used as a reference in mass 
spectra to evaluate the amount of XTEN-E49am remaining in the supernatant after 
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electropolymerization. We prepared a solution of EDOT-S with a 1:1 mixture of 
sXTEN-noam and XTEN-E49am (0.4 mM, respectively), and electropolymerized 
on FTO. The solution formed a precipitate after electropolymerization. We 
collected the supernatant and analyzed the ratio of peak intensities of sXTEN-noam 
and XTEN-E49am by MALDI-TOF mass spectrometry to evaluate the ratio of 
sXTEN-noam and XTEN-E49am after electropolymerization (Figure 4.5). Notably, 
the ratio of protein peaks (XTEN-E49am/sXTEN-noam) decreased by 87% after 
polymerization (n = 3). This indicates that XTEN-E49am polymerized with EDOT-
S and precipitated as the dark blue solid, while sXTEN-noam largely remained in 
the supernatant. 
 
Figure 4.5. MALDI-TOF mass spectra for a 1:1 mixture of sXTEN-noam and XTEN-
E49am (a) before and (b) after electropolymerization with EDOT-S. After 
electropolymerization, the supernatant was collected from the rection mixture and subjected 
to the analysis. Sinapic acid (SA) was used as a matrix. 
Generality of the protein polymerization was investigated by introducing EDOT-
Lys at a different position. XTEN carrying EDOT-Lys at position 5 (XTEN-K5am) 
formed the dark blue precipitate when electropolymerized with EDOT-S (Figure 
S4.3a-c). MALDI-TOF mass spectrometry with the internal standard sXTEN-noam 
revealed that 83% (n = 3) of XTEN-K5am was depleted from the solution upon 
electopolymerization (Figure S4.3d). 
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4.3.2. FT-IR Spectroscopy for the Polymer Products 
We further analyzed the polymer products by FT-IR spectroscopy (Figure 4.6a). 
The solid product and the supernatant were separated by centrifugation, and the 
solid was washed with water to remove soluble PEDOT-S. The supernatant, solid 
product, and electropolymerized PEDOT-S were air dried at room temperature, 
mixed with KBr to form pellets, and subjected to FT-IR spectroscopy. 
Electropolymerized PEDOT-S showed peaks at around 1,683, 1,637, 1,180, 1,144, 
1,120, 1,109, 1,084, and 1,051 cm−1. The strongest peaks at 1,120 and 1,084 cm−1 
are attributed to the asymmetric and symmetric S=O stretching modes in the 
sulfonic acid side chain.25 The peak at 1,683 cm−1 is attributed to the stretching 
modes of C=C in the thiophene ring.26 On the other hand, the spectrum of pure 
XTEN-E49am showed characteristic amide peaks at 1,653 (amide I) and 1,539 
(amide II) cm−1. The supernatant and the solid products from electropolymerization 
of EDOT-S and XTEN-E49am showed peaks originating from PEDOT-S. In 
addition, the solid product showed a strong protein peak at 1522 cm−1, which 
suggests that XTEN-E49am was incorporated into the solid polymer product. The 
supernatant only showed a small peak at 1522 cm−1, which is consistent with the 
depletion of XTEN-E49am in the soluble fraction. 
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Figure 4.6. FT-IR spectroscopy of the polymer products. (a) FT-IR spectra of (i) XTEN-
E49am, (ii) electropolymerized PEDOT-S, (iii) the supernatant, and (iv) the solid product 
in the reaction mixture of EDOT-S and XTEN-E49am. (b) FT-IR spectra of mixtures of 
XTEN-E49am and PEDOT-S mixed at the indicated mass ratio. Dot lines indicate the 
characteristic peaks of XTEN-E49am (1522 cm-1) and PEDOT-S (1084 cm-1). (c) The 
intensity ratios of peaks of XTEN-E49am (1522 cm-1) and PEDOT-S (1084 cm-1) plotted 
against mass ratio (XTEN-E49am/PEDOT-S). The curve was fit with the following 
functional form: y = (ax + b)/(cx + d). (a = 2642, b = 1059, c = 2027, d = 9937). 
In order to determine the protein and PEDOT-S composition of the solid product, 
we prepared a calibration curve using the mixture of a fixed amount of PEDOT-S 
and variable amount of XTEN-E49am (Figure 4.6b). We observed a stronger 
protein peak at 1522 cm−1 relative to the peak of PEDOT-S (1,084 cm−1) as the 
amount of XTEN-E49am increased. The ratios of peak intensities (1522 cm−1/1,082 
cm−1) were plotted against mass ratios of XTEN-E49am and PEDOT-S (Figure 
4.6c) to create a calibration curve. The mass composition of XTEN-E49am and 
PEDOT-S in the solid product was calculated as 73:27. This indicates that one 
protein is found per 13 monomer units of the PEDOT chain. 
4.3.3. Conductivity of the XTEN–PEDOT Conjugate 
We studied the electrical conductivity of the solid product that was 
electropolymerized from the mixture of EDOT-S and XTEN-E49am. In order to 
measure the sheet resistance of the sample in a two-electrode configuration,27 we 
deposited two parallel-aligned Pt electrodes on a glass substrate  (Figure 4.7a). The 
purified solid product was dispersed in water, cast between the two Pt electrodes, 
and air dried overnight (Figure 4.7b). A potential sweep (Elow = 0 V; Ehigh = +0.1 V) 
between the two electrodes showed linear increase in the current (Figure 4.7c), 
which gave a sheet resistance of (2.6 ± 0.7) x 102 kΩ (n = 4). Conductivity is given 
by σ = !" =
#
$%& , where ρ is resistivity, R is resistance, L is the spacing between the 
two electrodes, W is the width of the sample, and t is the thickness of the sample, 
and calculated as (4.6 ± 1.7) x 10-3 S/cm (n = 4). 
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Figure 4.7. Conductivity measurement. (a) Two parallel-aligned Pt electrodes deposited 
on a glass substrate. Thickness of the Pt electrodes is 10 nm. (b) The solid product of 
electropolymerization was cast in the defined area between the two electrodes. The area 
was defined by the scotch tape attached with a spacing of 4 mm. Sample thickness was 8.9 
± 1.3 µm (n = 4).  (c) A representative I-E curve of the solid product from 
electropolymerization of XTEN-E49am with EDOT-S. Average resistance and 
conductivity were calculated as (2.6 ± 0.7) x 102 kΩ and (4.6 ± 1.7) x 10-3 S/cm (n = 4), 
respectively. 
4.3.4. Effect of Adjacent Amino Acids 
The chemical environment around EDOT-Lys might have an impact on 
electropolymerization. To investigate the effect of the amino acid adjacent to 
EDOT-Lys, we prepared a series of short peptides as a model and evaluated their 
electropolymerization. Peptides with EDOT-Lys are readily synthesized from 
Fmoc-protected peptides carrying Lys residue via the reaction with EDOT-NHS. 
We prepared a series of model peptides with the sequence of STXZS (X = EDOT-
Lys, Z = Cys, Glu, Gly, His, Lys, Met, Pro, Gln, Arg, and Trp) and performed 
electropolymerization by cyclic voltammetry (Figure 4.8). Peptides carrying Glu, 
Gly, His, Pro and Gln adjacent to EDOT-Lys showed the onset of an oxidation 
current at ~1.1 V and the solutions turned blue upon oxidation. When Cys, Lys, or 
Met was located adjacent to EDOT-Lys, the peptides did not show a current 
response, and no color change was observed in the solution. The peptide with Trp 
showed the initiation of the current production at ~0.9 V, which corresponds to the 
oxidation potential of the indole group in Trp. The solution revealed no color 
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change, indicating that polymerization was inhibited by the presence of Trp 
adjacent to EDOT-Lys. Interestingly, the peptide carrying Arg showed a higher 
oxidation potential (~1.3V) compared to the other peptides that proceeded 
polymerization (~1.1 V). 
 
Figure 4.8. Electropolymerization of model peptides. (a) Chemical structure of model 
peptides (STXZS; X = EDOT-Lys, Z = indicated amino acid). Cyclic voltammograms of 
model peptides carrying the adjacent amino acid Z = (a) Cys, (b) Asp, (c) Glu, (d) Gly, (e) 
His, (f) Lys, (g) Met, (h) Pro, (i) Gln, (j) Arg, and (k) Trp. Peptide solutions were prepared 
at 50 mM in H2O with 100 mM NaClO4 and 5% TFA. The potential was swept between 
+0.65 V and +1.5 V (vs Ag/AgCl) at a scan rate of 100 mV/s. 
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Because the amino acids Cys, Lys, Met, Arg, and Trp showed influence on 
electropolymerization of the model peptides, we analyzed the effect of these amino 
acids in the context of polymerization of the XTEN protein and EDOT-S. We 
prepared a series of protein variants XTEN-E49am-G50Z (Z = Cys, Lys, Met, Arg, 
Trp) and performed electropolymerization with EDOT-S by cyclic voltammetry 
(Figure S4.4). Notably, all the samples showed an oxidation current with the onset 
of current production at ~1.1 V, similar to electropolymerization of XTEN-E49am 
with EDOT-S. The solutions turned dark blue during the potential cycles, which 
indicates the formation of a PEDOT chain. Dark blue precipitates were formed in 
all the samples (Figure 4.9a), and aggregates were observed under an optical 
microscope (Figure 4.9b). Polymerization of the XTEN variants without EDOT-
Lys (XTEN-noam-G50Z (Z = Cys, Lys, Met, Arg, Trp)) formed no precipitate in 
the solutions (Figure 4.9a). These results indicate that proteins carrying EDOT-Lys 
can polymerize with EDOT-S regardless of the presence of adjacent Cys, Lys, Met, 
Arg, and Trp residues, whereas these residues inhibited peptide polymerization or 
increased the oxidation potential (Figure 4.8). A possible explanation of this is that 
in protein polymerization, the EDOT-S monomer supplemented to assist protein 
polymerization enabled formation of radical species to initiate the reaction. In 
contrast, EDOT-S was not added in the peptide polymerization experiment, and the 
initial oxidation step was hampered by the adjacent Cys, Lys, Met, Arg, and Trp 
residues. 
 
Figure 4.9. Electropolymerization of XTEN-E49am-G50Z. (a) Solutions after 
electropolymerization of XTEN-E49am-G50Z or XTEN-noam-G50Z (Z = Cys, Lys, Met, 
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Arg, Trp) with EDOT-S. (b-f) Optical microscope images of sample solutions after 
electropolymerization of XTEN-E49am-G50Z  with EDOT-S. Z = (b) Cys, (c) Lys, (d) 
Met, (e) Arg, and (f) Trp. Scale bar: 25 µm. Solutions were cast between two glass cover 
slips with a 120 µm spacer. 
4.4. Conclusion 
We performed electropolymerization of XTEN proteins carrying EDOT-Lys. The 
solution containing XTEN-E49am and EDOT-S monomer yielded dark blue solids 
upon the application of the oxidation potential. MALDI-TOF mass spectrometry 
with an internal standard protein revealed that 85% of the protein was consumed in 
the reaction mixture. FT-IR spectroscopy indicated that the solid product contained 
both protein and PEDOT-S (one protein in 12.5 monomer units). The effect of 
adjacent amino acids was investigated in the model peptide and XTEN proteins. 
These results suggest that genetic incorporation of EDOT-Lys can be used for the 
synthesis of protein–PEDOT conjugates and provides a versatile strategy to 
fabricate protein-based conductive materials. 
4.5. Experimental Procedures 
4.5.1. General 
All the reagents for organic synthesis were purchased from Sigma Aldrich and used 
as received without further purification. Fmoc-protected peptides were custom 
synthesized by GenScript. For column chromatography, Biotage Isolera Spektra 
equipped with a SNAP ULTRA C18 12 g cartridge was used. 1H (500 MHz) and 
13C NMR (126 MHz) spectra were recorded on a Varian Inova 500 spectrometer. 
High-resolution mass spectrometry (HRMS) was performed with an LCT Premier 
XE Electrospray TOF Mass Spectrometer with electrospray ionization (ESI) at the 
Caltech CCE Multiuser Mass Spectrometry Laboratory. Matrix-assisted laser 
desorption/ionization time-of-flight mass (MALDI-TOF MS) spectrometry 
measurements were carried out on a Bruker Daltonics autoflexTM speed MALDI-
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TOF/TOF spectrometer at the Caltech CCE Multiuser Mass Spectrometry 
Laboratory. IR absorption data was collected on a Thermo Nicolet Nexus FT-IR 
spectrometer using an LN2-cooled MCT-A detector. The sample chamber was 
purged with nitrogen.  
4.5.2. Synthesis and Characterization of the Peptides 
 
 
Peptides with EDOT group. General procedure for synthesis of peptides with 
EDOT group is as follows: Fmoc-protected peptide with Lys (100 mg) and 
sodium bicarbonate (48 mg, 0.57 mmol) were dissolved in dioxane:H2O (4:1, 1 
mL). EDOT-NHS (6) (60 mg, 0.19 mmol) was added to the solution and the 
resulting mixture was allowed to stir at room temperature for 18 h. Then, DCM 
(0.6 mL) and piperidine (0.4 mL) were added and the solution was stirred for 16 h. 
After the completion of the reaction, the solution was poured into excess ether. 
The white precipitate was washed with ether three times, air dried, and purified by 
C18 reversed-phase silica column chromatography (H2O:methanol 98:2 to 0:100). 
 
STXCS. HRMS (ESI) calculated for C27H42N6O13S2 [M+H]+: m/z = 723.2329; 
found: 723.2302 
STXDS. HRMS (ESI) calculated for C28H42N6O15S [M+H]+: m/z = 735.2507; 
found: 735.2501 
STXES. HRMS (ESI) calculated for C29H44N6O15S [M+H]+: m/z = 749.2663; 
found: 749.2664 
STXFS. HRMS (ESI) calculated for C33H46N6O13S [M+H]+: m/z = 767.2922; 
found: 767.2941 
STXGS. HRMS (ESI) calculated for C26H40N6O13S [M+H]+: m/z = 677.2452; 
found: 677.2452 
STXHS. HRMS (ESI) calculated for C30H44N8O13S [M+H]+: m/z = 757.2827; 
found: 757.2816 
STXKS. A peptide Fmoc-STK(FmocK)S was used as starting material. HRMS 
(ESI) calculated for C30H49N7O13S [M+H]+: m/z = 748.3187; found: 748.3171 
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STXMS. HRMS (ESI) calculated for C29H46N6O13S2 [M+H]+: m/z = 751.2642; 
found: 751.2642 
STXPS. HRMS (ESI) calculated for C29H44N6O13S [M+H]+: m/z = 717.2765; 
found: 717.2755 
STXQS. HRMS (ESI) calculated for C29H45N7O14S [M+H]+: m/z = 748.2823; 
found: 748.2808 
STXRS. HRMS (ESI) calculated for C30H49N9O13S [M+H]+: m/z = 776.3249; 
found: 776.3256 
STXWS. HRMS (ESI) calculated for C35H47N7O13S [M+H]+: m/z = 806.3031; 
found: 806.3049 
STXYS. HRMS (ESI) calculated for C33H46N6O14S [M+H]+: m/z = 783.2871; 
found: 783.2883 
*The peptides (Z = F, Y) were insoluble in aqueous solutions and not used for the 
electropolymerization experiment. 
4.5.3. Cloning, Protein Expression, and Purification 
Cloning. The plasmids were constructed by standard recombinant DNA technology 
using E. coli DH10B strain. DNA oligomers for PCRs were purchased from IDT 
(Coralville, IA). Bacteria were grown on LB/agar plates and LB liquid media with 
the following antibiotic concentrations: 100 μg/mL spectinomycin and 100 μg/mL 
ampicillin. The plasmid encoding XTEN was a kind gift from Dr. Peter Rapp. 
Plasmids and their corresponding coding sequences are presented in 4.7. DNA and 
Protein Sequences. 
pET16b-XTEN Plasmids. The pET16b vector (Novagen) confers resistance to 
ampicillin and carries an N-terminal 10xHis-Tag and cloning sites under the T7 
promoter. The XTEN gene was cloned to a cloning site by Gibson Assembly. N-
terminal 10xHis-Tag was removed, and 6xHis-Tag was introduced to the C-
terminus. A modified FLAG-Tag was introduced to the N-terminus to improve 
protein expression. An amber stop codon was introduced at the indicated position 
by site-directed mutagenesis. 
Protein Expression and Purification. To express XTEN carrying EDOT-Lys, E. 
coli strain BL21(DE3) was co-transformed with pUltra-MmPylRS(Y306A/Y384F) 
and a pET plasmid encoding XTEN. E. coli cultures were grown in 2xYT media at 
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37 °C to an optical density at 600 nm (OD600) of 0.5-0.7. Then 1 mM EDOT-Lys 
was added, and protein expression was induced by addition of 1 mM IPTG. After 
15 h, the cells were harvested by centrifugation, resuspended in a lysis buffer (0.1 
M Na2HPO4, 10 mM imidazole; pH 8.0), and lysed by sonication. Lysates were 
cleared by centrifugation, and incubated with Ni-NTA agarose. The resin was 
washed with a lysis buffer and wash buffer (0.1 M Na2HPO4, 25 mM imidazole; pH 
8.0). Protein was eluted with elution buffer (0.1 M Na2HPO4, 250 mM imidazole; 
pH 8.0), dialyzed against water, and lyophilized for storage. 
To express the control XTEN without EDOT-Lys, E. coli strain BL21(DE3) was 
transformed with a pET plasmid encoding XTEN. E. coli cultures were grown in 
2xYT media at 37 °C to an optical density at 600 nm (OD600) of 0.5-0.7. Then 
protein expression was induced by addition of 1 mM IPTG. After 6 h, the cells 
were harvested by centrifugation, resuspended in lysis buffer (0.1 M Na2HPO4, 10 
mM imidazole; pH 8.0), and lysed by sonication. Lysates were cleared by 
centrifugation and incubated with Ni-NTA agarose. The resin was washed with 
lysis buffer and wash buffer (0.1 M Na2HPO4, 25 mM imidazole; pH 8.0). Protein 
was eluted with elution buffer (0.1 M Na2HPO4, 250 mM imidazole; pH 8.0), 
dialyzed against water, and lyophilized for storage. 
4.5.4. Electropolymerization 
Electropolymerization was performed by cyclic voltammetry in a three-electrode 
configuration using a fluorine-doped tin oxide (FTO) working electrode, Ag/AgCl 
reference electrode, and Pt counter electrode. The Ag/AgCl electrode was placed in 
a pipette tip filled with 1% agarose gel in 3M NaCl. The FTO electrodes were 
cleaned by sonication in acetone, ethanol, and deionized water, and dried in the air. 
The SecureSeal Imaging Spacer (d = 9 mm; Grace Bio Labs) was attached to the 
FTO electrodes to define the conductive surface area (0.025 m2). Sample solution 
(40 µL) was cast on the FTO electrode, and the Ag/AgCl and the Pt electrodes were 
immersed in the solution. Five potential cycles were applied between +0.65 V and 
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+1.5 V vs Ag/AgCl at a scan rate of 100 mV/s. All the experiments were carried out 
at room temperature. 
4.5.5. FT-IR Spectroscopy 
IR absorption measurement. The reaction mixture of electropolymerization of 
EDOT-S (25 mM) and XTEN-E49am (0.9 mM) was centrifuged, and the 
precipitate and the supernatant were collected separately. The precipitate was 
washed with water three times to remove water-soluble PEDOT-S. The 
supernatant and the solid product were air dried at room temperature, mixed with 
KBr, and subjected to FT-IR spectroscopy. 
Composition analysis. Standard samples were prepared at 0:1, 0.32:1, 0.64:1, 
1.28:1, and 2.56:1 mass ratio of XTEN-E49am and electropolymerized PEDOT-S. 
Samples were dried in the air at room temperature and mixed with KBr to form 
pellets. The absorbance values of characteristic peaks of XTEN-E49am (1522 cm-1) 
and PEDOT-S (1084 cm-1) were used to create a calibration curve. 
4.5.6. Conductivity Measurement 
Two-electrode sheet resistance measurement was performed following a reported 
procedure with minor modifications.27 Two parallel-aligned Pt electrodes (thickness 
= 10 nm) were deposited on a glass substrate using a plastic mask prepared by a 3D 
printer. After electropolymerization of XTEN-E49am with EDOT-S, the solid 
products were isolated by centrifugation and washed with water five times to 
remove water-soluble PEDOT-S. The solid products were resuspended in water and 
cast between the two Pt electrodes deposited on the glass substrate. The samples 
were dried in the air at room temperature overnight and a potential sweep (Elow = 0 
V; Ehigh = +0.1 V) was applied to measure the current response. Four independent 
samples were analyzed. Sample thickness was measured using a DekTakXT stylus 
profiler (Bruker). 
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4.6. Supporting Figures 
 
Figure S4.1. Study of monomer consumption by NMR spectroscopy. 1H NMR spectrum 
(500 MHz) of EDOT-S in D2O (a) before and (b) after electropolymerization. Monomer 
consumption was calculated as 97% based on the reduction in the integration value of (i) 
the thiophene peaks relative to that of (ii) the methylene peaks. Related to Figure 4.2a. 
Electropolymerization was conducted by cyclic voltammetry on FTO electrodes (Elow = 
+0.65 V; Ehigh = +1.5 V; scan rate = 100 mV/s; 5 cycles). The sample for 
electropolymerization was prepared at [EDOT-S] = 25 mM, [NaClO4] = 100 mM in D2O 
with 5% TFA-d. 
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Figure S4.2. MALDI-TOF mass spectra for (a) XTEN-noam and (b) XTEN-E49am before 
and after electropolymerization with EDOT-S. The major peaks correspond to the 
molecular weight of methionine-cleaved proteins (*indicates the peaks from proteins 
without methionine cleavage). Samples after electropolymerization were collected by 
dissolving the deposited films on the FTO electrodes into water. Sinapic acid (SA) was 
used as a matrix. 
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Figure S4.3. Electropolymerization of EDOT-S with XTEN-49am-K5am by cyclic 
voltammetry on FTO electrodes. (a) Cyclic voltammogram (Elow = +0.65 V; Ehigh = +1.5 V; 
scan rate = 100 mV/s; 5 cycles). Sample was prepared at [XTEN-K5am] = 0.8 mM, 
[EDOT-S] = 25 mM, [NaClO4] = 100 mM in H2O with 5% TFA. Arrows indicate the scan 
direction. (b, c) Optical microscope images of the solution after electropolymerization of 
EDOT-S with XTEN-49am-K5am. Scale bar: (b) 100 µm, (c) 25 µm. (d) MALDI-TOF 
mass spectra for a 1:1 mixture of sXTEN-noam and XTEN-K5am before and after 
electropolymerization with EDOT-S. After electropolymerization, the supernatant was 
collected from the reaction mixture and subjected to the analysis. Sinapic acid (SA) was 
used as a matrix. 
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Figure S4.4. Electropolymerization of EDOT-S with XTEN-E49am-G50Z by cyclic 
voltammetry on FTO electrodes (Elow = 0.65 V; Ehigh = +1.5 V; scan rate = 100 mV/s; 5 
cycles). Z = (a) Cys, (b) Lys, (c) Met, (d) Arg, and (e) Trp. Samples are prepared at 
[XTEN] = 0.8 mM, [EDOT-S] = 25 mM, [NaClO4] = 100 mM in H2O with 5% TFA. 
Arrows indicate the scan direction. 









*The positions 5 and 49 are highlighted in red. C-terminal 6xHis-Tag is highlighted 
in blue. The six amino acids deleted in sXTEN-noam are highlighted with 
underlining. 
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C h a p t e r  5  
CHEMICAL POLYMERIZATION OF XTEN WITH AN EDOT 
GROUP 
5.1. Abstract 
PEDOT is often synthesized either by electropolymerization or oxidative chemical 
polymerization. While electropolymerization has advantages such as a short 
reaction time and the requirement of only a small sample volume, chemical 
polymerization does not require electrochemical instruments and is suitable for 
large scale synthesis. In this chapter, we describe chemical polymerization of the 
XTEN protein and model peptides carrying an EDOT group. When XTEN carrying 
EDOT-Lys was polymerized in the presence of an EDOT-S monomer, the reaction 
mixture yielded a dark blue precipitate. To demonstrate the reactivity of the pendant 
EDOT group in the protein, we performed oxidation reaction XTEN carrying 
EDOT-Lys with an end-capped EDOT derivative (EDOT-cap). Mass spectrometry 
showed the peaks of protein species that correspond to the XTEN with one or two 
EDOT-caps, indicating that XTEN can react with the EDOT-cap through the 
pendant EDOT group. We further studied the effect of the chemical environment on 
polymerization using a series of model peptides. In the reaction without an FeCl3 
catalyst, we found that neighboring basic residues (His, Lys, Arg) enhanced 
polymerization. These results provide valuable information for fabrication of 







PEDOT and its derivatives are often synthesized by two major approaches: 
electrochemical polymerization and oxidative chemical polymerization.1,2 
Electrochemical polymerization has advantages such as short reaction time and the 
requirement of only a small volume of sample solutions. On the other hand, 
oxidative chemical polymerization does not require electrochemical instruments 
and is advantageous in the production of polymers at large scales. In this chapter, 
we studied chemical polymerization of the XTEN protein and model peptides 
carrying EDOT-Lys. 
In the standard method of oxidative chemical polymerization, ammonium persulfate 
(APS), iron(III) chloride (FeCl3), and iron tosylate (Fe(OTs)3) are commonly used 
as oxidants.1,2 In particular, polymerization by persulfates is usually performed in 
aqueous solution and suitable for polymerization in the presence of biomolecules.3–5 
Addition of a catalytic amount of Fe salts accelerates the reaction.2,3  
Progress of the polymerization is often visible to the eye because of the 
characteristic dark blue color of PEDOT and its derivatives.6 In UV-vis 
spectroscopy, they exhibit absorption bands at 600 nm (neutral), 800 nm (polaron), 
and <1200 nm (bipolaron).7 Polaron is the expected state when the polymer is 
lightly doped, whereas the bipolaron is the expected state when the polymer is 
heavily doped.8 Because the pristine PEDOT is insoluble in any common solvent, 
typical solution-based analytical techniques (e.g. gel permeation chromatography 
(GPC), NMR spectroscopy) cannot be used for the characterization of PEDOT. 
This limitation hampers the detailed analysis of some properties of PEDOT, such as 
molecular weight.6,7 The general length of PEDOT chain is believed to be about 10-
20 repeating units9 based on the studies using electron microscopy10 and MALDI-
TOF mass spectrometry11 as well as the analysis of PEDOT derivatives.12,13  
5.3. Results and Discussion 
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5.3.1. Chemical Polymerization of XTEN with an EDOT Group 
To study the oxidative chemical polymerization of proteins containing EDOT-Lys, 
we prepared a model protein XTEN-E49am (XTEN with EDOT-Lys at position 
49). XTEN-E49am was mixed with the self-doping EDOT monomer EDOT-S12,14 
in 100 mM HCl, and polymerization was initiated by addition of APS as an oxidant 
and FeCl3 as a catalyst (Figure 5.1a). The solution gradually turned blue within 10 
min. After stirring at room temperature for 18 hours, we observed dark blue 
precipitates in the solution, whereas polymerization of the EDOT-S monomer and 
the EDOT-S monomer with XTEN-noam did not form any precipitate. In UV-vis 
spectra of the reaction mixtures, the electropolymerized product from the EDOT-S 
monomer exhibited a broad absorption peak in the 600-1000 nm region with 
increasing absorption towards longer wavelengths, which is characteristic of 
heavily doped PEDOT species (Figure 5.1b).7 The product from the mixture of 
EDOT-S and XTEN-noam showed less absorption in the 600-1000 nm region 
compared to the product from EDOT-S, suggesting that oxidation was diminished 
in the presence of the XTEN protein. The product from EDOT-S and XTEN-
E49am showed marginal absorption in the 600-1000 nm region, because the dark 
blue solid product was insoluble and precipitated in the solution (Figure 5.1c). 
 
Figure 5.1. Oxidative chemical polymerization of EDOT-S and XTEN. (a) Schematic 
illustration of chemical polymerization of EDOT-S and XTEN. (b) UV-vis spectra of (i) 
 92 
EDOT-S, (ii) EDOT-S and XTEN-noam, and (iii) EDOT-S and XTEN-E49am after 
chemical polymerization. The reaction mixtures were stirred at room temperature for 18 
hours, and the supernatant was analyzed by UV-vis spectroscopy. 
5.3.2 Reactivity Test with End-capped EDOT 
The polymer product from EDOT-S and XTEN-E49am was insoluble in water (pH 
2 and pH 9) and  in common organic solvents such as DMSO, DMF, THF, 
methanol, ethanol, hexafluoroisopropanol (HFIP), and acetonitrile. The insoluble 
nature of the product hampers characterization by solution-based analytical 
techniques,7 and therefore, proving the reactivity of EDOT-Lys is challenging. To 
circumvent this problem, we performed a reactivity test using an end-capped EDOT 
derivative (EDOT-cap). EDOT-cap carries a reactive α proton on one end and a 
triethylene glycol-substituted phenyl protecting group on the other end. Therefore, 
reaction with XTEN carrying EDOT-Lys will yield protein species with the 
addition of one or two EDOT-caps (Figure 5.2a), which should have better 
solubility than XTEN-PEDOT and can be analyzed by MALDI-TOF mass 
spectrometry. The unreacted EDOT-cap and the dimerized byproduct diEDOT-cap 
are soluble in ethanol while the XTEN protein is insoluble in ethanol. This enables 
the purification of protein species via ethanol precipitation. 
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Figure 5.2. Reactivity test with end-capped EDOT (EDOT-cap). (a) Schematic illustration 
of the reactivity test with EDOT-cap. R: -(C6H4)-(OC2H4)3CH3. (b, c) MALDI-TOF mass 
spectra of (b) Q-XTEN-A15am and (c) Q-XTEN-noam before and after reaction with 
EDOT-cap. Sinapic acid was used as matrix. Arrows indicate the mass peaks corresponding 
to the addition of one or two EDOT-caps to Q-XTEN-A15am. 
The oxidation reaction was performed in 100 mM HCl using APS as an oxidant and 
FeCl3 as a catalyst. The solution turned red due to some extension of the π-
conjugated system. After 18 hours, the unreacted EDOT-cap and diEDOT-cap were 
removed by ethanol wash and proteins were analyzed by MALDI-TOF mass 
spectrometry. XTEN carrying EDOT-Lys (Q-XTEN-A15am) showed the 
appearance of two protein peaks that correspond to the addition of one or two 
EDOT-caps to Q-XTEN-A15am (Figure 5.2b). By contrast, XTEN carrying no 
EDOT-Lys (Q-XTEN-noam) showed no peak that corresponds to the addition of 
EDOT-cap (Figure 5.2c). These results indicate that XTEN carrying the EDOT-Lys 
reacted with EDOT-cap through the pendant EDOT group. 
5.3.3. Chemical Polymerization of Model Peptides 
The chemical environment around the EDOT group can influence the chemical 
polymerization of proteins. To investigate the effect of adjacent amino acids, we 
prepared a series of model peptides with the sequence of STXZS (X = EDOT-Lys, 
Z = Cys, Glu, Gly, His, Lys, Met, Pro, Gln, Arg, Trp) and performed chemical 
polymerization (Figure 5.3). When the peptides were polymerized by APS without 
a catalytic amount of FeCl3, peptides with adjacent basic residues (Z = His, Lys, 
Arg) showed strong absorption peaks at 780 nm, which is characteristic to the 
formation of PEDOT chains. On the other hand, the peptides with adjacent non-
basic residues (Z = Asp, Glu, Gly, Met, Pro, Gln) showed only a little absorption at 
780 nm. These results indicate that basic residues enhance chemical polymerization. 
When the peptides were polymerized by APS with FeCl3 catalyst, all the peptides 
(Z = Asp, Glu, Gly, His, Lys, Met, Pro, Gln, Arg) showed broad absorption in the 
780-1100 nm region, which indicates the formation of highly doped PEDOT.7 
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MALDI-TOF mass spectra of the model peptides (Z = Cys, Asp, Glu, Gly, His, Lys, 
Met, Pro, Gln, Arg, Trp) showed peaks corresponding to the oligomers of model 
peptides (n = 1-10) (Figure 5.4). Some peptides with aromatic amino acids (Z = Phe, 
Tyr) were insoluble in water and only showed the peaks of small oligomers (n = 1-
5). 
 
Figure 5.3. Oxidative chemical polymerization of model peptides. (a, b) UV-vis spectra of 
model peptides (STXZS, Z = indicated amino acid) chemically polymerized by APS (a) 
with or (b) without an FeCl3 catalyst. Z = D (sienna), E (red), G (green), H (magenta), K 
(blue), M (orange), P (deep sky blue), Q (slate blue), R (purple). (c, b) Absorbance at 780 
nm of the samples polymerized (c) with or (d) without FeCl3. *: peptides were insoluble in 
water. **: polymer products were insoluble in water. 
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Figure 5.4. MALDI-TOF mass spectra of chemically polymerized peptides. 
Polymerization was performed by APS without an FeCl3 catalyst. α-cyano-4-
hydroxycinnamic acid (CHCA) was used as a matrix. Phe and Tyr: peptides were insoluble 
in water. Cys and Trp: polymer products were insoluble in water. 
5.4. Conclusion 
We investigated the oxidative chemical polymerization of the XTEN protein and 
model peptides. The polymerization of XTEN carrying EDOT-Lys with EDOT-S 
monomer formed a dark blue precipitate in the solution. A reactivity test using end-
capped EDOT revealed that EDOT-Lys in the XTEN protein can react with the 
EDOT derivative. In addition, study of the effect of the chemical environment on 
polymerization revealed that peptides with a basic residue adjacent to EDOT-Lys 
enhance polymerization by APS without an FeCl3 catalyst. The results presented 
here provide valuable insight into the synthesis of protein–PEDOT conjugates via 
oxidative chemical polymerization. 
5.5. Experimental Procedures 
5.5.1 General 
 96 
All the reagents for organic synthesis were purchased from Sigma Aldrich and 
Tokyo Chemical Industry Co., Ltd. (TCI), and used as received without further 
purification. For column chromatography, Biotage Isolera Spektra equipped with a 
SNAP HP-Sil 10 g cartridge was used. 1H (500 MHz) and 13C NMR (126 MHz) 
spectra were recorded on a Varian Inova 500 spectrometer. Analytical HPLC 
analyses for small compounds were performed with an Agilent 1290 Infinity Series 
HPLC instrument at the Center for Catalysis and Chemical Synthesis in the Caltech 
Beckman Institute.	 High-resolution mass spectrometry (HRMS) was performed 
with an LCT Premier XE Electrospray TOF Mass Spectrometer with electrospray 
ionization (ESI) at the Caltech CCE Multiuser Mass Spectrometry Laboratory. 
Matrix-assisted laser desorption/ionization time-of-flight mass (MALDI-TOF MS) 
spectrometry measurements were carried out on a Bruker Daltonics autoflexTM 
speed MALDI-TOF/TOF spectrometer at the Caltech CCE Multiuser Mass 
Spectrometry Laboratory. Absorption spectra were recorded using a Varian Cary 50 
UV–visible spectrophotometer. 
5.5.2. Synthesis and Characterization of the Compounds 
 
EDOT-cap. 1-Bromo-4-{2-[2-(2-methoxy-ethoxy)-ethoxy]-ethoxy}-benzene (5) 
was synthesized following the reported procedure.15 EDOT boronic acid pinacol 
ester (4) (100 mg, 0.37 mmol), compound 5 (119 mg, 0.37 mmol), and cesium 
carbonate (365 mg, 1.12 mmol) were dissolved in THF:H2O (7:1, 8 mL). After 
addition of PdCl2(dppf)CH2Cl2 (31 mg, 0.04 mmol), the solution was degassed for 
20 min with Ar and heated to 90 ºC. After 18 h, the reaction mixture was cooled to 
room temperature, poured into brine (50 mL), and extracted with DCM (3 x 20 
mL). The combined organic layers were dried over MgSO4, concentrated in vacuo, 
 97 
and purified by silica gel chromatography (hexane:ethyl acetate 95:5 to 50:50) 
yielding 64 mg (45%) of yellow oil. 1H NMR (500 MHz, CDCl3) δ 7.61 (d, J = 8.7 
Hz, 2H), 6.91 (d, J = 8.8 Hz, 2H), 6.23 (s, 1H), 4.26 (m, 4H), 4.14 (dd, J = 5.7, 4.1 
Hz, 2H), 3.86 (dd, J = 5.6, 4.1 Hz, 2H), 3.78 – 3.51 (m, 8H), 3.38 (s, 3H).; 13C 
NMR (126 MHz, CDCl3) δ 157.74, 142.33, 137.31, 127.45, 126.25, 117.50, 114.94, 
114.94, 96.57, 72.09, 70.99, 70.80, 70.71, 69.88, 67.64, 64.84, 64.62, 59.15. HRMS 
(ESI) calculated for C19H24O6S [M+H]+: m/z = 381.1372; found: 381.2972. 
5.5.3. Cloning, Protein Expression, and Purification 
Cloning. The plasmids were constructed by standard recombinant DNA technology 
using E. coli DH10B strain. DNA oligomers for PCRs were purchased from IDT 
(Coralville, IA). Bacteria were grown on LB/agar plates and LB liquid media with 
the following antibiotic concentrations: 100 μg/mL spectinomycin and 100 μg/mL 
ampicillin. The plasmid encoding XTEN was a kind gift from Dr. Peter Rapp. 
Plasmids and their corresponding coding sequences are presented in 5.7. DNA and 
Protein Sequences. 
pQE80-XTEN Plasmids. The pQE80 vector (Novagen) confers resistance to 
ampicillin and carries an N-terminal 6xHis-Tag and cloning sites under the T5 
promoter. The XTEN gene was cloned to a cloning site by Gibson Assembly. An 
amber stop codon was introduced at position 15 by site-directed mutagenesis. 
Protein Expression and Purification. To express the XTEN carrying EDOT-Lys, 
E. coli strain BL21(DE3) was co-transformed with pUltra-
MmPylRS(Y306A/Y384F) and a pQE plasmid encoding XTEN. E. coli cultures 
were grown in 2xYT media at 37 °C to an optical density at 600 nm (OD600) of 
0.5-0.7. Then 1 mM EDOT-Lys was added, and protein expression was induced by 
addition of 1 mM IPTG. After 15 h, the cells were harvested by centrifugation, 
resuspended in a lysis buffer (0.1 M Na2HPO4, 10 mM imidazole; pH 8.0), and 
lysed by sonication. Lysates were cleared by centrifugation and incubated with Ni-
NTA agarose. The resin was washed with a lysis buffer and wash buffer (0.1 M 
 98 
Na2HPO4, 25 mM imidazole; pH 8.0). Protein was eluted with elution buffer (0.1 M 
Na2HPO4, 250 mM imidazole; pH 8.0), dialyzed against water, and lyophilized for 
storage. 
To express the control XTEN without EDOT-Lys, E. coli strain BL21(DE3) was 
transformed with a pQE plasmid encoding XTEN. E. coli cultures were grown in 
2xYT media at 37 °C to an optical density at 600 nm (OD600) of 0.5-0.7. Then 
protein expression was induced by addition of 1 mM IPTG. After 6 h, the cells 
were harvested by centrifugation, resuspended in the lysis buffer (0.1 M Na2HPO4, 
10 mM imidazole; pH 8.0), and lysed by sonication. Lysates were cleared by 
centrifugation and incubated with Ni-NTA agarose. The resin was washed with a 
lysis buffer and wash buffer (0.1 M Na2HPO4, 25 mM imidazole; pH 8.0). Protein 
was eluted with elution buffer (0.1 M Na2HPO4, 250 mM imidazole; pH 8.0), 
dialyzed against water, and lyophilized for storage. 
5.5.4. Chemical Polymerization and Reactivity Test 
For oxidative chemical polymerization of proteins, EDOT-S (25 mM) and XTEN 
protein (1 mM) were dissolved in 100 mM HCl. To initiate polymerization, APS 
(40 mM) and FeCl3 (2 mM) were added, and the reaction mixtures were stirred at 
room temperature for 18 hours. The reaction mixtures were diluted 80-fold with 
water, and absorption spectra were recorded using a UV-vis spectrophotometer. 
For reactivity test using EDOT-cap, XTEN protein (1 mM) and EDOT-cap (25 
mM) were dissolved in 100 mM HCl. To initiate oxidation, APS (40 mM) and 
FeCl3 (2 mM) were added, and the reaction mixtures were stirred at room 
temperature for 18 hours. Then excess amount of ethanol was added to the solution 
to precipitate protein. After removal of the supernatant, protein was redissolved in a 
small volume of water and washed with ethanol three more times. The resultant 
protein product was redissolved in water and subjected to MALDI-TOF mass 
spectrometry. 
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For oxidative chemical polymerization of model peptides, model peptides (50 mM) 
were dissolved in 100 mM HCl. To initiate polymerization, APS (40 mM) or APS 
(40 mM) and FeCl3 (2 mM) were added, and the reaction mixtures were stirred at 
room temperature for 20 hours. The reaction mixtures were diluted 80-fold with 
water, and absorption spectra were recorded using a UV-vis spectrophotometer. For 
mass spectrometry, the reaction mixtures were dialyzed against water overnight and 
analyzed by MALDI-TOF mass spectrometry. 
5.6. NMR Spectra 
 
Figure S5.1. 1H NMR spectrum (500 MHz) of EDOT-cap in CDCl3 at 22 ºC. 
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Figure S5.2. 13C NMR spectrum (126 MHz) of EDOT-cap in CDCl3 at 22 ºC. 








*The position 15 is highlighted in red. N-terminal 6xHis-Tag is highlighted in blue.  
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